Benign neoplasm: Colon

CD2_BENIGN_COLON

colonic neoplasm: A benign or malignant neoplasm that affects the colon. Representative examples of benign neoplasms include lipoma and leiomyoma. Representative examples of malignant neoplasms include carcinoma, lymphoma, and sarcoma. Colonic adenomas always exhibit epithelial dysplasia and are considered premalignant neoplasms.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints CD2_BENIGN_CAECUM CD2_BENIGN_APPENDIX CD2_BENIGN_ASCENDING_COLON CD2_BENIGN_TRANSVERSE_COLON CD2_BENIGN_DESCENDING_COLON CD2_BENIGN_SIGMOID_COLON CD2_BENIGN_COLON_NOS	31209
6. Filter based on genotype QC (FinnGen only)	28072

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	CD2_BENIGN_COLON
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	CD2_BENIGN_CAECUM\|CD2_BENIGN_APPENDIX\|CD2_BENIGN_ASCENDING_COLON\|CD2_BENIGN_TRANSVERSE_COLON\|CD2_BENIGN_DESCENDING_COLON\|CD2_BENIGN_SIGMOID_COLON\|CD2_BENIGN_COLON_NOS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Colon based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	132400	65346	66373
Only index persons	122287	61626	60661
Unadjusted period prevalence (%)
Whole population	1.86	1.87	1.85
Only index persons	2.29	2.27	2.32
Median age at first event (years)
Whole population	66.72	66.73	66.70
Only index persons	66.32	66.30	66.33

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	28072	13786	14286
Unadjusted period prevalence (%)	5.74	4.89	6.55
Median age at first event (years)	66.58	65.45	67.68

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
28957: Matched controls
271604

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

323.3

4499

23426

B01AB05

ATC

enoxaparin; parenteral

1.7

321.2

9943

65350

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

317.9

3518

16878

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

309.4

3340

15865

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

133.2

307.7

4564

381

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.8

307.7

3343

12262

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

3.2

307.7

2547

8042

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.1

307.7

13079

56875

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

3.0

307.7

3152

10467

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

20.1

307.7

2018

1007

Z12.1

ICD-10 Finland

Special screening examination for neoplasm of intestinal tract

6.8

307.7

821

1165

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

112.2

307.7

4656

463

D64.9

ICD-10 Finland

Anaemia, unspecified

2.3

307.7

4324

19616

N02BE01

ATC

paracetamol; systemic, rectal

2.2

307.7

26177

220673

P01AB01

ATC

metronidazole; oral, rectal

1.6

307.7

11325

76417

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

307.7

11694

67123

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

101.0

307.7

2918

301

JFA42

NOMESCO Finland

Endoscopic injection in colon

48.7

307.7

485

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

413.0

307.7

11868

456

K64.0

ICD-10 Finland

First degree haemorrhoids

3.9

307.7

1020

2520

K63.5

ICD-10 Finland

Polyp of colon

4.7

307.7

1272

2612

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.3

307.7

4419

20110

D12.1

ICD-10 Finland

Benign neoplasm: Appendix

386.2

307.7

406

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

115.9

307.7

6231

641

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

48.5

307.7

10724

3256

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.4

307.7

2988

12405

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

9.4

307.7

3678

4139

UJH02

NOMESCO Finland

Anoscopy

3.0

307.7

1538

4992

K92.1

ICD-10 Finland

Melaena

2.8

307.7

2236

7875

UJF30

NOMESCO Finland

Ileoscopy through colon

6.4

307.7

7419

13831

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

6.6

307.7

944

1373

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

11.7

307.7

415

336

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

307.7

6297

35146

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

307.7

15834

108972

A02BC02

ATC

pantoprazole; systemic

1.8

307.7

21032

160371

JFA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in colon

98.4

307.7

260

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

13.0

307.7

336

245

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

9.0

307.7

749

795

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

153.7

307.7

8661

752

JFA52

NOMESCO Finland

Other endoscopic haemostatic procedure in colon

39.9

307.7

461

110

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

4.8

307.7

11603

33281

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

4.5

307.7

4892

11769

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

7.1

307.7

870

1178

UJF32

NOMESCO Finland

Coloscopy

12.7

307.7

20563

43975

A06AC01

ATC

ispaghula (psylla seeds); oral

2.2

307.7

9805

50757

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

15.2

307.7

454

285

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

307.7

7286

41969

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

3.1

307.7

2450

7881

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

292.5

6919

42176

A02BC05

ATC

esomeprazole; systemic

1.6

288.9

11978

83881

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

277.7

4289

23018

R06.0

ICD-10 Finland

Dyspnoea

1.6

276.9

8444

54826

WX002

NOMESCO Finland

Sedation and analgesia

1.7

276.5

5983

35506

J01DB01

ATC

cefalexin; oral

1.7

269.0

23442

193467

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

7.2

264.5

404

531

N02AX02

ATC

tramadol; systemic, rectal

1.5

264.0

12899

93099

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

255.5

8750

58179

K62.1

ICD-10 Finland

Rectal polyp

5.4

255.5

525

932

UJF92

NOMESCO Finland

Capsular endoscopy

3.8

248.5

788

1979

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

3.4

246.1

935

2649

Z2221

NOMESCO Finland

Medical doctor

1.6

244.2

7476

48298

C03CA01

ATC

furosemide; systemic

1.5

242.6

9828

67704

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

240.7

5138

30235

D01

ICPC

Abdominal pain/cramps general

1.9

238.6

3401

17717

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

4.8

238.5

560

1117

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

7.3

237.4

361

472

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.5

237.1

1589

6145

A02BC03

ATC

lansoprazole; oral

1.6

235.3

8447

56549

H02AB06

ATC

prednisolone; systemic

1.5

235.0

13820

102795

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

4.3

232.4

629

1406

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.7

225.1

1254

4424

J01MA02

ATC

ciprofloxacin; systemic

1.5

221.6

11509

83121

JN4AD

NOMESCO Finland

Body CT examination

1.8

220.5

3930

21912

R03AC02

ATC

salbutamol; inhalant

1.5

220.0

14750

112049

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.9

218.0

1101

3686

S18

ICPC

Laceration/cut

1.5

216.5

13985

105323

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

214.9

2885

14703

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

8.5

209.4

278

309

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.4

207.3

1593

6548

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

9.2

205.9

258

266

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

205.1

11820

86733

C07AB07

ATC

bisoprolol; oral

1.5

203.8

14945

114792

K59.09

ICD-10 Finland

Constipation, unspecified

2.0

202.6

2308

11097

N03AX16

ATC

[U] pregabalin

1.6

201.3

6663

43503

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

201.2

7256

48292

A07EC02

ATC

mesalazine; oral, rectal

2.3

199.9

1547

6376

JFB30

NOMESCO Finland

Right hemicolectomy

4.0

197.4

586

1403

C05AA08

ATC

fluocortolone; rectal, topical

1.7

197.2

3972

22876

M79.6

ICD-10 Finland

Pain in limb

1.5

196.5

12162

90229

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

191.8

10212

73502

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

3.0

190.9

910

2949

K55.2

ICD-10 Finland

Angiodysplasia of colon

5.9

184.5

339

541

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

184.4

18951

153654

UKC02

NOMESCO Finland

Cystoscopy

1.6

183.3

5064

31597

D16

ICPC

Rectal bleeding

3.0

182.8

873

2831

AA1AD

NOMESCO Finland

CT of head and brain

1.5

181.1

8806

62094

G47.3

ICD-10 Finland

Sleep apnoea

1.5

178.6

6560

43640

R4110

NOMESCO Finland

Physiotherapy

1.5

176.6

7889

54638

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

175.9

4366

26502

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

175.8

7524

51655

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.1

175.3

1705

7713

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

2.5

174.8

1172

4522

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

5.9

174.0

324

524

M54.5

ICD-10 Finland

Low back pain

1.4

172.4

9638

69638

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

172.3

5278

33686

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

171.4

19045

155454

K29.7

ICD-10 Finland

Gastritis, unspecified

2.5

170.9

1171

4563

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

170.5

7391

50812

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

169.7

3532

20459

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

169.0

3765

22207

JN4BD

NOMESCO Finland

Extensive body CT

1.7

168.2

3175

17898

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.4

167.4

1204

4797

K59.1

ICD-10 Finland

Functional diarrhoea

2.1

167.3

1689

7748

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

166.8

5206

33337

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

166.5

12030

90873

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

3.0

165.9

781

2512

A06AD11

ATC

lactulose; oral

1.6

165.2

4386

27031

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

27.5

164.9

117

R53

ICD-10 Finland

Malaise and fatigue

1.5

161.0

6737

45893

UJG02

NOMESCO Finland

Proctoscopy

2.9

160.6

783

2568

N06AX11

ATC

mirtazapine; oral

1.4

157.5

9149

66296

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

157.3

5406

35310

JFB21

NOMESCO Finland

Laparoscopic ileocaecal resection

16.6

156.4

136

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

156.4

2886

16144

A02BC01

ATC

omeprazole; systemic

1.5

156.2

7553

52877

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

4.0

156.1

464

1112

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

155.4

10186

75366

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

154.6

10848

81195

R03BB04

ATC

tiotropium bromide; inhalant

1.7

153.4

3115

17891

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

150.9

9905

73203

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

150.2

6642

45642

C08CA01

ATC

amlodipine; oral

1.4

149.2

11748

89493

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.3

149.1

1153

4741

A10BA02

ATC

metformin; oral

1.4

149.1

8385

60269

J01AA02

ATC

doxycycline; systemic

1.4

148.0

21625

182466

J01CA04

ATC

amoxicillin; systemic

1.4

146.9

21745

183753

T90

ICPC

Diabetes non-insulin dependent

1.4

146.8

7409

52171

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.7

146.4

2952

16908

C10AA05

ATC

atorvastatin; oral

1.4

146.2

12946

100417

SPAT1263

SPAT

Sampling

1.4

145.7

10916

82367

K30

ICD-10 Finland

Functional dyspepsia

1.7

143.8

3061

17787

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

142.9

7530

53400

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

3.7

142.4

472

1221

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

142.1

13374

104575

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

142.0

4354

27657

A07EA06

ATC

budesonide; oral, local oral

2.4

141.3

1055

4270

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

139.0

5665

38212

G04CA02

ATC

tamsulosin; oral

1.4

138.8

7288

51596

D06

ICPC

Abdominal pain localized other

1.8

138.6

2370

12946

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

138.3

7811

56021

Z3231

NOMESCO Finland

Registered nurse

1.4

137.0

7336

52097

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

136.9

5203

34585

K51.5

ICD-10 Finland

Left sided colitis

2.8

136.6

733

2530

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

136.6

3252

19435

K59.0

ICD-10 Finland

Constipation

2.0

136.5

1699

8390

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

135.6

4362

27980

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

135.2

7862

56633

D11

ICPC

Diarrhoea

1.7

134.1

2789

16087

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

132.7

4828

31782

R02

ICPC

Shortness of breath/dyspnoea

1.6

132.4

3945

24860

L17

ICPC

Foot/toe symptom/complaint

1.4

130.9

8448

61878

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.3

129.7

999

4097

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

4.1

129.1

365

843

I84.5

ICD-10 Finland

External hemorrhoids without complication

2.5

129.0

869

3356

8263/2-C18.0

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of cecum

59.6

128.8

207

Kela drug reimbursment

Chronic arrhythmias

1.5

128.8

4975

33130

XKD00

NOMESCO Finland

Uroflowmetry

1.5

128.7

4794

31690

J01MA12

ATC

levofloxacin; systemic

1.5

128.2

5252

35385

R42

ICD-10 Finland

Dizziness and giddiness

1.4

128.0

6585

46326

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.5

127.9

871

3381

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.5

126.9

826

3138

A02BA02

ATC

ranitidine; systemic

1.5

126.1

5295

35835

C189, 8211, 2

ICD-O-3

23.3

124.8

WX402

NOMESCO Finland

General anaesthesia

1.4

124.7

5844

40382

B01AA03

ATC

warfarin; systemic

1.5

124.5

5534

37854

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

124.0

3327

20438

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

124.0

4149

26791

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.8

123.9

2048

11062

Z3226

NOMESCO Finland

Physiotherapist

1.5

123.5

4738

31478

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

123.5

5376

36622

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

123.2

3666

23064

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

121.5

4301

28093

C187, 8211, 2

ICD-O-3

22.8

121.2

N05CF01

ATC

zopiclone; oral

1.4

120.7

8824

65764

H02AB07

ATC

prednisone; oral

1.6

120.6

3681

23282

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

120.5

5048

34108

R51.80

ICD-10 Finland

Headache

1.6

119.9

3574

22484

XF402

NOMESCO Finland

ECG with work load test

1.6

119.9

3061

18572

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

119.8

6824

48783

L03

ICPC

Low back symptom/complaint

1.4

119.7

7441

53991

A98

ICPC

Health maint/preventive medicine

1.8

118.7

27048

241688

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

3.8

118.1

366

904

UJF30, ,

SPAT

4.0

117.9

340

797

E0000UV, ,

ATC

1.3

117.7

10758

82905

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

2.9

116.8

552

1778

A04

ICPC

Weakness/tiredness general

1.5

115.6

4124

26954

M25.5

ICD-10 Finland

Pain in joint

1.4

115.6

8196

60689

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

115.5

2823

16938

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

112.6

11865

93170

C10AA01

ATC

simvastatin; oral

1.3

112.3

12533

99212

A10BH01

ATC

sitagliptin; oral

1.6

112.2

2793

16825

R07.3

ICD-10 Finland

Other chest pain

1.6

111.9

2864

17370

M04AA01

ATC

allopurinol; systemic

1.5

111.6

3873

25151

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

111.3

6793

49022

ZXA00

NOMESCO Finland

Right side

1.4

111.3

7145

51997

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

111.1

13985

112543

ZX120

NOMESCO Finland

Intravenous

1.6

110.4

2522

14870

A06AC51

ATC

ispaghula, combinations; oral

2.0

109.9

1339

6553

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

109.8

2913

17815

UJF34

NOMESCO Finland

Left colonoscopy

4.3

109.8

293

648

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

108.6

4635

31361

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

108.4

18143

151691

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

108.3

6994

50907

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

107.8

4528

30538

WX892

NOMESCO Finland

Monitored bed care

1.7

107.5

2136

12138

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

4.1

107.2

307

716

N03AX12

ATC

[U] gabapentin; oral

1.5

107.0

4247

28323

R60.0

ICD-10 Finland

Localized oedema

1.5

106.9

3649

23597

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

3.7

106.7

352

908

8263/2-C18.9

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of colon, NOS

17.6

106.4

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.1

106.0

1130

5274

J01FA06

ATC

roxithromycin; oral

1.3

105.2

10127

78261

R01AD09

ATC

mometasone; nasal

1.3

103.7

10903

85264

Z01.7

ICD-10 Finland

Laboratory examination

1.5

103.3

4286

28813

B01AF02

ATC

apixaban; oral

1.5

103.2

4128

27553

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

5.4

102.8

207

361

SPAT1153

SPAT

Removal of sutures

1.3

102.5

8563

64756

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

5.0

101.8

222

416

C10AC01

ATC

colestyramine; oral

2.3

101.3

791

3261

C03DA01

ATC

spironolactone; oral

1.5

101.2

3580

23303

UJD02

NOMESCO Finland

Gastroscopy

1.9

100.4

1343

6780

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

100.2

5662

40220

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

2.4

99.9

721

2872

B80

ICPC

Iron deficiency anaemia

2.4

99.8

705

2781

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.7

99.7

1824

10125

I84

ICD-10 Finland

Hemorrhoids

2.3

99.2

752

3061

D12

ICPC

Constipation

2.0

99.2

1125

5368

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

99.2

7248

53659

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

99.1

2867

17863

ZXA05

NOMESCO Finland

Left side

1.4

98.7

6599

48174

R52.9

ICD-10 Finland

Pain, unspecified

1.6

98.6

2719

16754

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

98.2

9490

73182

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

2.5

98.1

657

2529

K64.1

ICD-10 Finland

Second degree haemorrhoids

2.4

97.8

669

2600

ZXD05

NOMESCO Finland

Urgent procedure

1.4

97.6

7359

54712

C01DA14

ATC

isosorbide mononitrate; oral

1.4

97.6

4518

30970

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

97.5

9306

71613

SPAT1104

SPAT

Monitoring of emergency patient

1.7

97.5

1749

9652

M48.0

ICD-10 Finland

Spinal stenosis

1.5

97.5

3657

24076

J01DA01

ATC

[U] cefalexin

1.3

97.4

15906

131538

B82

ICPC

Anaemia other/unspecified

2.2

97.4

880

3854

D18

ICPC

Change in faeces/bowel movements

2.3

97.2

777

3236

R03BA02

ATC

budesonide; inhalant

1.4

97.2

4361

29720

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

3.8

96.8

299

737

R19.4

ICD-10 Finland

Change in bowel habit

2.2

96.6

852

3696

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

95.7

1851

10429

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

94.8

1780

9948

N06AX21

ATC

duloxetine; oral

1.5

94.7

2901

18296

JGA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in rectum

9.5

94.6

115

114

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

94.3

4312

29471

SFA10

NOMESCO Finland

One-surface restoration

1.3

94.1

13564

110145

K57

ICD-10 Finland

Diverticular disease of intestine

2.4

94.0

648

2528

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

93.9

1828

10318

JFB51

NOMESCO Finland

Other laparoscopic resection of colon

16.4

93.7

G44.2

ICD-10 Finland

Tension-type headache

1.5

93.7

3123

20054

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.8

93.0

480

1623

J01FF01

ATC

clindamycin; systemic

1.3

92.9

6947

51512

L01BC06

ATC

capecitabine; oral

1.9

91.9

1129

5536

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.9

91.5

1239

6277

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

91.3

4836

33905

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

91.2

8599

65906

L04AX01

ATC

azathioprine; systemic

2.0

91.1

1046

5010

R31

ICD-10 Finland

Unspecified haematuria

1.5

90.9

2988

19124

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

90.6

3224

20975

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.1

90.2

851

3791

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

89.7

3650

24384

M03BX02

ATC

tizanidine; oral

1.3

89.7

15698

130318

H02AB04

ATC

methylprednisolone; systemic

1.5

89.5

3672

24567

C187, 8148, 2

ICD-O-3

12.6

89.3

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

89.3

4693

32846

GD1AD

NOMESCO Finland

Thorax CT examination

1.7

89.0

1835

10514

K64.8

ICD-10 Finland

Other specified haemorrhoids

3.5

88.8

319

871

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.3

88.7

665

2693

J02AC01

ATC

fluconazole; systemic

1.3

88.6

9001

69633

R50.9

ICD-10 Finland

Fever, unspecified

1.4

88.3

3800

25652

A01

ICPC

Pain general/multiple sites

1.5

87.6

2667

16781

R13

ICD-10 Finland

Dysphagia

1.7

87.2

1925

11224

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.9

86.9

1200

6117

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

86.6

6463

47820

R35

ICD-10 Finland

Polyuria

1.6

85.4

1961

11547

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

85.3

3557

23857

D64.8

ICD-10 Finland

Other specified anaemias

2.4

85.2

582

2261

J45

ICD-10 Finland

Asthma

1.5

84.4

2493

15575

R96

ICPC

Asthma

1.5

84.3

2575

16205

A02BC04

ATC

rabeprazole; oral

1.6

84.3

2137

12889

M79.1

ICD-10 Finland

Myalgia

1.5

84.3

3426

22861

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

84.3

1987

11776

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

83.7

1885

11042

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

83.6

2853

18383

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

83.3

10429

82736

M10.9

ICD-10 Finland

Gout, unspecified

1.6

83.0

2046

12256

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

82.9

11139

89137

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.0

82.6

964

4643

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.7

82.6

1676

9557

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.2

82.6

691

2933

K02.1

ICD-10 Finland

Caries of dentine

1.3

82.4

14194

117047

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

82.1

2026

12137

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

4.0

82.1

241

573

WX722

NOMESCO Finland

PEEP

1.8

81.6

1256

6620

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

81.1

3159

20897

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.6

80.9

1929

11461

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

80.6

4604

32617

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

3.9

80.5

245

598

N06AB04

ATC

citalopram; systemic

1.4

80.2

5015

36046

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

5.2

80.2

170

311

Z01.2

ICD-10 Finland

Dental examination

1.3

80.1

11136

89362

Z71.8

ICD-10 Finland

Other specified counselling

1.3

80.0

8267

63891

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

3.9

79.9

244

597

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

79.9

5634

41257

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

79.8

2609

16651

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

2.6

79.6

462

1660

SPAT1301

SPAT

No procedures

1.3

79.6

8015

61724

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

79.4

2517

15957

A07AA02

ATC

nystatin; oral

1.7

79.4

1563

8839

JFB46

NOMESCO Finland

Resection of sigmoid colon

3.0

79.3

365

1159

N05BA04

ATC

oxazepam; oral

1.3

79.3

6440

48139

R05

ICD-10 Finland

Cough

1.4

79.1

5420

39506

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

4.6

78.8

193

399

XF404

NOMESCO Finland

Ambulatory ECG

1.5

78.7

2305

14362

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

78.5

3595

24505

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

78.4

16088

135080

A28

ICPC

Limited function/disability NOS

1.4

77.8

5138

37223

R63.4

ICD-10 Finland

Abnormal weight loss

1.8

77.4

1127

5838

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

76.6

5628

41427

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

76.5

2497

15923

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.8

76.5

1274

6873

R03DC03

ATC

montelukast; oral

1.4

76.4

3754

25899

G04BD12

ATC

mirabegron; oral

1.4

76.2

3431

23302

K78

ICPC

Atrial fibrillation/flutter

1.5

76.1

2267

14176

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.6

75.6

450

1637

U07

ICPC

Urine symptom/complaint other

1.5

75.6

2329

14668

A10AE04

ATC

insulin glargine; parenteral

1.5

75.6

2516

16110

R03AC03

ATC

terbutaline; inhalant

1.4

75.5

3203

21515

R11

ICD-10 Finland

Nausea and vomiting

1.6

75.2

2074

12746

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

74.8

8907

69959

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.7

74.3

1541

8831

D12

ICD-10 Finland

Benign neoplasm of colon, rectum, anus and anal canal

4.1

74.2

205

466

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

74.1

6666

50464

8263/2-C18.7

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of sigmoid colon

17.4

74.0

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

74.0

9553

75753

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

73.9

2527

16268

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

73.9

3632

25048

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

73.8

5077

36976

N06AX16

ATC

venlafaxine; oral

1.5

73.7

3027

20201

JFB43

NOMESCO Finland

Left hemicolectomy

3.9

73.6

218

522

S29

ICPC

Skin symptom/complaint other

1.3

73.6

5355

39330

A10BH05

ATC

linagliptin; oral

1.7

73.3

1489

8488

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

73.2

7263

55689

A11

ICPC

Chest pain NOS

1.5

73.2

2338

14835

K64.2

ICD-10 Finland

Third degree haemorrhoids

2.6

73.2

446

1642

D07AC01

ATC

betamethasone; topical

1.3

73.1

9369

74202

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

3.3

72.9

288

836

A07EA02

ATC

hydrocortisone; rectal

2.3

72.8

544

2201

A10BK03

ATC

empagliflozin; oral

1.5

72.6

2837

18753

JGA73

NOMESCO Finland

Transanal excision of lesion of rectum

6.4

72.3

123

182

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

72.3

3358

22918

JHB00

NOMESCO Finland

Hemorrhoidectomy

2.0

72.3

821

3916

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

72.2

5084

37142

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

71.9

1840

11109

R06AE07

ATC

cetirizine; oral

1.3

71.9

10382

83358

SPAT1097

SPAT

Recording of ECG

1.4

71.4

3876

27170

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

71.3

2011

12416

2113X

ICD-9 Finland

Benign neoplasm of other parts of digestive system, Colon[NEOPLASMA BENIGNUM ALIUD COLI]

+∞

71.2

2113C

ICD-9 Finland

Benign neoplasm of other parts of digestive system, Colon[ADENOMA TUBULARE COLI]

+∞

71.2

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.7

70.3

1474

8468

JF2BD

NOMESCO Finland

Extensive colon CT

3.2

70.2

286

846

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

2.3

70.1

559

2325

G04CA01

ATC

alfuzosin; oral

1.4

70.0

3432

23641

3AC01, ,

NOMESCO Finland

3.2

69.8

281

825

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

69.8

4882

35609

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

69.7

2739

18116

N02BF01

ATC

gabapentin; oral

1.5

69.6

2631

17269

D02

ICPC

Abdominal pain epigastric

1.7

69.4

1487

8592

A08

ICPC

Swelling

1.6

69.1

1594

9383

WX290

NOMESCO Finland

Other blockage of nerve

1.3

69.0

10354

83381

G04CB01

ATC

finasteride; oral

1.4

68.9

3104

21057

R01AD08

ATC

fluticasone; nasal

1.3

68.8

6501

49451

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.7

68.7

1435

8236

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

68.6

3510

24349

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

68.6

3416

23588

B01AC04

ATC

clopidogrel; oral

1.3

68.4

4670

33926

B01AB10

ATC

tinzaparin; parenteral

1.4

68.4

2857

19113

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

68.3

2300

14747

N17

ICPC

Vertigo/dizziness

1.4

68.2

3351

23080

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

68.1

2833

18937

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

1.7

68.0

1229

6784

C10AX09

ATC

ezetimibe; oral

1.3

68.0

4733

34483

N02BF02

ATC

pregabalin; oral

1.6

67.6

1677

10046

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

4.5

67.6

168

352

J20

ICD-10 Finland

Acute bronchitis

1.5

67.2

2476

16165

B01AF01

ATC

rivaroxaban; oral

1.4

67.0

3548

24748

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

66.9

2847

19105

SFA20

NOMESCO Finland

Two-surface restoration

1.2

66.9

14082

117607

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

66.8

1582

9370

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.4

66.8

2912

19630

R19.5

ICD-10 Finland

Other faecal abnormalities

2.4

66.6

478

1899

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

66.5

6373

48529

SPAT1262

SPAT

Handing over of treatment supplies

1.3

66.1

4564

33192

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

2.0

65.9

693

3215

WX320

NOMESCO Finland

Spinalanesthesy

1.3

65.9

6417

48963

SPAT1312

SPAT

General health counselling

1.3

65.8

7379

57318

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.5

65.6

2207

14143

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

65.6

9464

75744

C09CA01

ATC

losartan; oral

1.3

65.6

7106

54958

E66.00

ICD-10 Finland

Metabolic syndrome

1.7

65.4

1392

8025

JAH01

NOMESCO Finland

Laparoscopy

1.8

65.4

1016

5367

K55.8

ICD-10 Finland

Other vascular disorders of intestine

4.1

65.3

184

425

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

65.2

5114

37882

M01AH05

ATC

etoricoxib; oral

1.2

65.0

15837

134163

R03BA05

ATC

fluticasone; inhalant

1.4

65.0

4144

29770

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.6

64.9

1525

9013

J01FA10

ATC

azithromycin; systemic

1.2

64.7

13318

110788

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

64.5

3164

21772

SPAT1254

SPAT

Administration of medicine

1.4

64.4

3658

25796

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.5

64.3

2482

16345

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.9

63.9

883

4497

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

2.5

63.7

403

1511

1381

FHL

Colonoscopy and polyp removal

35.9

63.7

K51.8

ICD-10 Finland

Other ulcerative colitis

2.7

63.5

339

1168

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

63.3

5131

38165

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

63.1

2436

16042

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

62.9

7156

55621

M02AA07

ATC

piroxicam; topical

1.3

62.9

9285

74415

205

Kela drug reimbursment

Chronic hypertension

1.3

62.6

7412

57881

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.1

62.5

624

2840

A10BK01

ATC

dapagliflozin; oral

1.5

62.4

2146

13811

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

62.3

6307

48299

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.7

62.3

1295

7419

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

62.1

3958

28410

D78

ICPC

Neoplasm digestive benign/unspecif

7.3

62.0

120

C09CA06

ATC

candesartan; oral

1.3

62.0

6171

47155

R15

ICD-10 Finland

Faecal incontinence

1.9

62.0

768

3775

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

6.3

61.9

106

158

JDA05

NOMESCO Finland

Endoscopic polypectomy in stomach or pylorus

4.1

61.9

172

393

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

61.9

1767

10927

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

61.9

2204

14284

C189, 8148, 2

ICD-O-3

17.2

61.8

A10AB05

ATC

insulin aspart; parenteral

1.5

61.8

1867

11691

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.1

61.8

603

2721

H04.10

ICD-10 Finland

Dry eye syndrome

1.4

61.5

2864

19519

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

2.7

61.3

349

1243

C180, 8148, 2

ICD-O-3

28.9

61.3

JG1CG

NOMESCO Finland

Extensive MRI of rectum

3.5

60.9

210

559

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.6

60.9

1331

7724

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

2.9

60.8

301

996

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.8

60.7

1033

5603

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

60.7

4942

36750

J01FA09

ATC

clarithromycin; systemic

1.3

60.7

7203

56227

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

60.6

3991

28779

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

60.6

16490

140808

R05

ICPC

Cough

1.3

60.3

6040

46162

N05CF02

ATC

zolpidem; oral

1.3

60.3

4001

28883

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

60.3

10455

85168

N30.0

ICD-10 Finland

Acute cystitis

1.3

60.2

4070

29463

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

60.1

2474

16483

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.7

60.1

1274

7336

SFA30

NOMESCO Finland

Three-surface restoration

1.2

59.9

10556

86126

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.8

59.8

873

4524

R5110, ,

SPAT

1.5

59.7

2368

15665

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.3

59.7

4210

30664

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

59.7

2931

20155

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

3.0

59.5

274

871

EBA00

NOMESCO Finland

Extraction of tooth

1.2

59.5

8673

69293

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

59.3

5754

43784

C18.51

ICD-10 Finland

Malignant tumor of flexura hiealis invasive carcinoma

6.2

59.3

104

159

JFA05

NOMESCO Finland

Endoscopic polypectomy in small intestine

12.9

59.3

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

5.4

59.2

120

211

A03FA02

ATC

cisapride; oral, rectal

1.5

59.2

1847

11644

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

59.1

7240

56698

A46

ICD-10 Finland

Erysipelas

1.3

59.0

3972

28731

C180, 8211, 2

ICD-O-3

29.6

58.9

J31.0

ICD-10 Finland

Chronic rhinitis

1.5

58.9

1881

11917

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

58.8

2032

13085

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

6.7

58.5

131

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

58.5

2955

20417

-, ,

ICD-10 Finland

2.1

58.2

583

2656

K22.7

ICD-10 Finland

Barrett oesophagus

2.4

58.1

397

1544

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

4.7

58.0

135

268

L05

ICPC

Flank/axilla symptom/complaint

1.6

58.0

1578

9652

JHA20

NOMESCO Finland

Excision of lesion of anal canal or perianal tissue

2.8

57.9

288

956

D13.3

ICD-10 Finland

Benign neoplasm: Other and unspecified parts of small intestine

4.3

57.9

152

333

130

Kela drug reimbursment

Malignant tumour

1.4

57.7

2388

15921

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

57.7

1924

12297

L01

ICPC

Neck symptom/complaint

1.4

57.7

3690

26476

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

57.7

1467

8834

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.8

57.6

875

4590

-60

ICPC

Result test/procedure

1.6

57.6

1363

8067

S97

ICPC

Chronic ulcer skin

1.5

57.6

1736

10862

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.1

57.5

599

2769

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

57.3

1861

11829

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

57.3

2501

16839

R01AD58

ATC

fluticasone, combinations; nasal

1.3

57.3

5050

37926

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.7

57.2

1027

5657

E66.8

ICD-10 Finland

Other obesity

1.7

57.0

1114

6279

K96

ICPC

Haemorrhoids

1.9

57.0

687

3346

WVA20

NOMESCO Finland

Medicine administration

1.9

56.8

730

3632

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

56.7

926

4964

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

1.5

56.5

1724

10813

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.8

56.3

893

4745

N06AB10

ATC

escitalopram; oral

1.3

56.3

4085

29853

A10BJ06

ATC

semaglutide; parenteral

1.6

56.2

1277

7481

Z71.9

ICD-10 Finland

Counselling, unspecified

1.5

56.2

1859

11861

R33

ICD-10 Finland

Retention of urine

1.5

56.0

2161

14217

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

55.9

2043

13297

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

55.9

7249

57069

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

55.8

3434

24483

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

55.8

5798

44456

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

55.7

4926

36992

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.5

55.6

1628

10120

SPAT1325

SPAT

Vaccination

1.2

55.3

8418

67445

J01EA01

ATC

trimethoprim; systemic

1.3

55.3

6049

46662

K29.8

ICD-10 Finland

Duodenitis

2.9

55.3

263

852

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.6

55.2

1190

6880

J01MA14

ATC

moxifloxacin; systemic

1.5

55.2

2185

14442

R03BA08

ATC

ciclesonide; inhalant

1.5

55.2

1974

12794

L15

ICPC

Knee symptom/complaint

1.3

55.2

6323

49051

J46

ICD-10 Finland

Status asthmaticus

1.9

55.1

679

3331

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.7

55.1

1136

6493

L08

ICPC

Shoulder symptom/complaint

1.3

54.9

5800

44547

K22.1

ICD-10 Finland

Ulcer of oesophagus

2.2

54.9

471

2021

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.0

54.9

626

2991

C07AA05

ATC

propranolol; systemic

1.3

54.6

4290

31693

I50.0

ICD-10 Finland

Congestive heart failure

1.5

54.6

2035

13295

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.5

54.5

1676

10526

L13

ICPC

Hip symptom/complaint

1.3

54.5

5094

38517

N06AA09

ATC

amitriptyline; systemic

1.4

54.5

2340

15701

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

54.4

4925

37086

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.6

54.3

1326

7907

K62.0

ICD-10 Finland

Anal polyp

2.8

54.2

274

918

N01

ICPC

Headache

1.5

54.1

1969

12801

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.6

54.0

1276

7549

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

53.9

1399

8460

TK800

NOMESCO Finland

Hemodialysis

2.1

53.9

553

2543

H25.8

ICD-10 Finland

Other senile cataract

1.4

53.8

3022

21226

C10AA07

ATC

rosuvastatin; oral

1.2

53.8

9108

73752

U02

ICPC

Urinary frequency/urgency

1.3

53.7

3620

26153

D19

ICPC

Teeth/gum symptom/complaint

1.3

53.7

6863

53890

A11CC03

ATC

alfacalcidol; systemic

2.0

53.6

607

2892

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

53.6

7763

61816

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

53.5

3330

23771

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

53.5

10542

86694

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

53.5

7076

55781

R03AK08

ATC

formoterol and beclometasone; inhalant

1.7

53.3

1060

6001

M01AE02

ATC

naproxen; oral, rectal

1.2

53.3

13555

114287

M54

ICD-10 Finland

Dorsalgia

1.4

53.3

2625

18043

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.7

53.2

979

5429

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

53.1

7053

55609

8263/2-C20.9

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of rectum, NOS

5.8

53.0

158

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

2.4

53.0

372

1465

21136

ICD-8 Finland

Benign neoplasm of other parts of digestive system, Coli sigmoidei

+∞

52.9

SPAT1255

SPAT

Intravenous administration of medicine

1.5

52.8

1659

10465

XG410

NOMESCO Finland

Flow-volume spirometry

1.7

52.6

932

5112

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.5

52.5

1486

9164

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

52.5

8670

69978

R20.2

ICD-10 Finland

Paraesthesia of skin

1.5

52.5

1543

9597

WYA10

NOMESCO Finland

Emergency care or similar visit

1.5

52.3

1501

9286

K57.2

ICD-10 Finland

Diverticular disease of large intestine with perforation and abscess

2.0

51.9

560

2624

A97

ICPC

No disease

1.3

51.8

4877

36878

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

51.6

5269

40251

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.8

51.5

855

4605

JEA01

NOMESCO Finland

Laparoscopic appendectomy

1.9

51.5

713

3635

XJH00

NOMESCO Finland

Transanal ultrasonography

1.5

51.4

1559

9760

D50

ICD-10 Finland

Iron deficiency anaemia

2.1

51.3

489

2187

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

51.3

5882

45571

SDA03

NOMESCO Finland

Periodontal treatment

1.2

51.2

9439

77003

JFA15, ,

SPAT

2.9

51.0

252

834

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

1.9

51.0

697

3539

R03AC13

ATC

formoterol; inhalant

1.6

50.9

1175

6908

R04.2

ICD-10 Finland

Haemoptysis

1.7

50.9

895

4899

C09AA05

ATC

ramipril; oral

1.2

50.8

6815

53746

TKC20

NOMESCO Finland

Catheterisation of bladder

1.5

50.8

1732

11113

JF1AD

NOMESCO Finland

Small bowel CT

3.0

50.6

223

692

R03BA01

ATC

beclometasone; inhalant

1.3

50.3

3245

23273

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

50.1

4477

33610

J37.0

ICD-10 Finland

Chronic laryngitis

1.8

50.1

778

4108

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.4

49.9

2303

15641

L12

ICPC

Hand/finger symptom/complaint

1.3

49.9

3962

29276

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.6

49.8

1312

7962

ZXE00

NOMESCO Finland

One hour or less

1.2

49.6

9276

75715

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.7

49.6

914

5069

WX882

NOMESCO Finland

High dependency care

1.9

49.5

679

3450

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.1

49.5

482

2174

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

49.3

6671

52631

KMAK, ,

NOMESCO Finland

1.2

49.2

11486

95773

L72.1

ICD-10 Finland

Trichilemmal cyst

1.5

49.2

1615

10278

ZXA10

NOMESCO Finland

Bilateral

1.3

49.2

4557

34363

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.4

49.1

2222

15039

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

49.0

2359

16137

R4190

NOMESCO Finland

Nutritional therapy

1.8

49.0

831

4503

A07EC01

ATC

sulfasalazine; oral, rectal

1.5

48.9

1782

11582

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.1

48.9

500

2297

JFB54

NOMESCO Finland

Laparoscopic resection of sigmoid colon with partial proctectomy

5.5

48.8

161

K58

ICD-10 Finland

Irritable bowel syndrome

2.0

48.8

533

2509

SPAT1216

SPAT

Assessment of functional ability

1.3

48.7

4014

29804

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

48.7

1430

8891

R74

ICPC

Upper respiratory infection acute

1.2

48.5

6257

49082

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

4.5

48.5

120

251

K29.4

ICD-10 Finland

Chronic atrophic gastritis

2.0

48.5

555

2656

R60.9

ICD-10 Finland

Oedema, unspecified

1.5

48.3

1458

9117

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.4

48.2

2192

14845

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

19519

151114

1.65

322.26

4.3

3.3

59.34

53.03

u/l

11.59

18345

140450

(3019309) Folate [Moles/volume] in Red Blood Cells

7554

46201

1.72

320.29

1.8

1117.15

1164.12

nmol/l

4.13

5854

34796

(3035350) Ketones [Presence] in Urine by Test strip

17340

130984

1.60

310.41

5.1

4.1

8.02

3.95

estimate

1.35

2963

28621

(3023368) Bacteria identified in Blood by Culture

11136

75794

1.61

309.26

5.1

4.5

—

(3027945) Reticulocytes/Erythrocytes in Blood

5917

32106

1.92

307.65

2.6

2.5

1.82

1.78

2.44

5294

28499

(3001604) Monocytes [#/volume] in Blood

17685

124635

1.85

307.65

7.6

6.3

0.61

e9/l

0.15

15265

105912

(40768797) Stomach Pathology biopsy report

7276

34004

2.34

307.65

1.4

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

8713

48909

1.96

307.65

1.3

1.71

1.74

u/ml

0.07

2042

12834

(3013115) Eosinophils [#/volume] in Blood

18137

128452

1.87

307.65

7.8

6.5

0.19

0.20

e9/l

0.85

15880

110957

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

23115

178773

2.05

307.65

5.7

4.5

14.04

13.22

mm/h

12.51

21708

166471

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

24704

189921

2.50

307.65

11.1

8.6

80.90

80.82

u/l

0.07

23790

180014

(3037467) Urinalysis macro (dipstick) panel - Urine

21654

166330

1.88

307.65

6.0

4.8

2.42

49.98

0.50

279

(3015736) pH of Urine

14652

103595

1.66

307.65

4.6

3.6

6.30

6.22

13.33

7953

56733

(3021960) Folate [Moles/volume] in Serum or Plasma

11676

76360

1.73

307.65

1.9

1.7

20.29

20.21

nmol/l

0.18

10087

64254

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

12951

81124

1.90

307.65

3.2

2.7

63.02

63.93

u/l

0.13

12121

74884

(3032080) INR in Blood by Coagulation assay

17351

124923

1.76

307.65

21.5

16.2

1.33

1.29

inr

15.84

14691

104760

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

6607

27766

2.60

307.65

4.7

4.2

15.46

29.13

ug/l

1.92

5587

22807

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

18431

133089

1.82

307.65

9.6

7.4

1.21

mmol/l

12.11

16558

114104

(3013826) Glucose [Moles/volume] in Serum or Plasma

19953

149730

1.80

307.65

6.7

5.2

6.87

6.80

mmol/l

5.05

19195

143026

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

16438

114725

1.80

307.65

3.3

2.8

—

estimate

—

(3018010) Neutrophils/Leukocytes in Blood

15966

115056

1.67

307.65

7.7

6.4

58.47

57.93

6.89

15174

109728

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

12532

85009

1.67

307.65

3.7

3.2

1610.57

1479.41

ng/l

1.92

10997

73920

(3022096) Basophils/Leukocytes in Blood

15934

115226

1.66

307.65

8.0

6.6

0.68

0.67

1.64

14951

107726

(3004789) Transferrin [Mass/volume] in Serum or Plasma

7943

42624

2.03

307.65

3.3

2.6

2.35

2.28

g/l

20.71

7441

39170

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

17023

119189

1.82

307.65

8.4

6.7

1.21

mmol/l

5.48

15912

109995

(3006315) Basophils [#/volume] in Blood

17775

125049

1.86

307.65

7.6

6.3

0.04

e9/l

0.14

15348

106259

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3961

19377

2.06

307.65

1.8

1.6

—

(3019198) Lymphocytes [#/volume] in Blood

17977

127108

1.86

307.65

7.6

6.3

1.86

1.89

e9/l

0.86

15897

110615

(3007164) IgA [Mass/volume] in Serum or Plasma

7760

42874

1.95

307.65

1.6

1.5

2.60

2.57

g/l

0.43

4475

25662

(3048689) Calprotectin [Mass/mass] in Stool

6304

26595

2.56

307.65

2.5

2.2

149.26

146.91

ug/g

0.18

5093

20964

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

19670

134426

2.16

307.65

7.7

6.8

11.47

11.90

umol/l

4.77

18893

128185

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

13503

94057

1.65

307.65

4.4

3.5

1.67

2.12

e6/l

—

(3031040) Bacteria [#/volume] in Urine by Automated count

21245

161053

1.89

307.65

6.2

4.9

467.92

1833.06

e6/l

5.76

187

2561

(3006504) Eosinophils/Leukocytes in Blood

15946

115136

1.67

307.65

7.8

6.5

2.82

2.85

1.19

14948

107681

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

26980

229030

2.54

307.65

25.9

17.8

25.87

26.14

mg/l

0.68

23985

191622

(3024561) Albumin [Mass/volume] in Serum or Plasma

17741

117652

2.07

307.65

6.6

5.0

35.23

35.17

g/l

0.77

16869

109836

(3019069) Monocytes/Leukocytes in Blood

15976

115464

1.66

307.65

8.0

6.6

9.07

9.02

1.16

14997

108003

(3001122) Ferritin [Mass/volume] in Serum or Plasma

16108

106667

1.94

307.65

4.2

3.0

130.43

150.04

ug/l

14.72

15069

98279

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

7455

39557

2.03

307.65

3.4

2.6

20.71

22.32

20.24

7056

36504

(3022948) Iron [Moles/volume] in Serum or Plasma

8396

45453

2.03

307.65

3.4

2.6

11.92

12.66

umol/l

18.08

7932

42061

(3013650) Neutrophils [#/volume] in Blood by Automated count

19363

139593

1.91

307.65

10.8

9.9

4.25

4.22

e9/l

1.31

16900

120288

(3033658) Prothrombin time (PT) actual/Normal

9967

64600

1.68

307.65

5.5

4.2

87.25

87.75

1.09

9786

63223

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

11898

66537

2.15

307.65

3.0

2.3

3.12

2.86

mg/l

23.45

10570

57019

(3022145) Colonoscopy Study observation

11824

23684

7.22

307.65

1.5

1.3

—

(40768804) Tissue Pathology biopsy report

14769

96621

1.89

307.65

2.6

2.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

16962

115808

1.90

307.65

2.6

2.2

95.44

95.57

pmol/l

0.13

9696

60968

(3002030) Lymphocytes/Leukocytes in Blood

16134

117546

1.65

307.65

7.9

6.6

26.31

26.85

7.77

15298

111130

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

10157

61530

1.84

307.65

2.9

2.5

—

(3023520) Reticulocytes [#/volume] in Blood

4686

25241

1.88

302.31

2.7

2.6

70.19

68.70

e9/l

2.10

3520

18686

(3009261) Glucose [Presence] in Urine by Test strip

17405

132027

1.59

301.97

5.1

4.1

0.76

0.31

estimate

0.41

2710

26881

(3018095) Leukocytes [#/volume] in Urine

13398

95688

1.58

300.98

5.2

4.1

81.10

114.39

e6/l

5.24

9824

68702

(3011397) Hemoglobin [Presence] in Urine by Test strip

9216

60377

1.63

295.65

4.8

3.9

0.36

0.26

0.37

631

(3021601) Nitrite [Presence] in Urine by Test strip

17078

129390

1.58

293.92

5.1

4.1

0.00

estimate

0.14

2882

27808

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

5203

29228

1.82

292.45

3.1

2.7

8.14

9.51

umol/l

4.85

4607

25689

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4690

25559

1.86

290.59

2.7

2.2

0.21

0.20

g/l

10.23

4414

23686

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

13839

100098

1.57

290.33

5.0

4.0

43.63

74.42

ng/l

3.46

10677

75011

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

7470

46598

1.68

289.06

3.6

3.1

1.13

1.18

e6/l

0.23

4304

25055

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2772

12817

2.14

273.65

1.8

1.7

1.57

1.58

g/l

0.07

2419

10934

(3002582) Erythrocytes [#/volume] in Urine

12156

86225

1.56

271.77

4.3

3.5

67.59

93.71

e6/l

1.52

9549

66260

(3002032) Base excess in Venous blood by calculation

4760

26644

1.81

268.29

4.8

3.8

1.60

1.83

mmol/l

4.32

4202

23500

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

14980

111566

1.54

266.19

2.9

2.4

78.49

900.28

nmol/l

0.50

13410

99847

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4355

23798

1.84

265.24

2.9

2.5

52.53

52.16

u/l

0.01

3704

20104

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4852

27412

1.79

264.77

4.8

3.8

5.78

5.82

kpa

2.06

4735

26794

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

25323

214149

1.87

261.29

6.4

5.4

1.95

1.98

mu/l

2.22

23564

196341

(3012544) pH of Venous blood

4896

27857

1.78

260.38

4.8

3.8

7.38

0.09

2950

16071

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11438

80651

1.55

258.62

3.8

3.3

34.53

34.97

u/l

0.14

10733

75789

(3030467) Casts [#/volume] in Urine by Automated count

10716

74563

1.55

256.73

4.2

3.4

0.43

0.45

e6/l

0.28

8102

55234

(3019977) pH of Arterial blood

5548

32841

1.72

256.28

7.9

7.6

7.42

0.36

3006

17930

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5545

32850

1.72

255.26

7.9

7.6

5.08

5.09

kpa

0.26

5346

31610

(3027801) Oxygen [Partial pressure] in Arterial blood

5542

32832

1.72

255.11

7.9

7.6

12.05

12.24

kpa

2.11

5334

31592

(3000991) Gas panel - Venous blood

4281

23589

1.82

252.70

9.6

8.9

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

21984

179347

1.62

252.69

5.0

4.4

15.02

14.94

pmol/l

5.32

20250

163238

(3003396) Base excess in Arterial blood by calculation

5498

32619

1.72

251.27

7.9

7.6

0.76

0.99

mmol/l

3.76

4604

27128

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1892

7770

2.37

247.76

1.5

1.4

268.60

263.44

ug/g

0.49

1159

4596

(3026493) Urate [Moles/volume] in Serum or Plasma

9916

68355

1.55

244.58

3.3

2.8

359.04

349.04

umol/l

16.88

8734

59565

(3019550) Sodium [Moles/volume] in Serum or Plasma

27342

238545

2.35

243.61

30.9

21.3

139.63

139.67

mmol/l

1.91

27041

234058

(3016502) Oxygen saturation in Arterial blood

5021

29351

1.73

240.92

8.2

7.9

95.50

95.48

0.05

4898

28356

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

6733

42519

1.63

240.84

3.9

3.2

2.49

2.54

e6/l

0.12

3552

20889

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5434

32480

1.70

240.34

4.2

4.5

237.08

246.60

u/l

2.79

5139

30806

(3024354) Oxygen [Partial pressure] in Venous blood

4113

22757

1.81

238.30

3.9

3.1

4.54

4.48

kpa

0.98

4008

22171

(3023103) Potassium [Moles/volume] in Serum or Plasma

27348

238928

2.32

237.15

31.2

21.5

3.99

mmol/l

0.18

27021

234136

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

8034

53133

1.58

236.17

2.0

1.7

1.27

1.38

mg/l

2.05

6382

42014

(3014111) Lactate [Moles/volume] in Serum or Plasma

4396

24880

1.77

235.75

8.0

7.5

1.34

1.36

mmol/l

0.40

4314

24366

(3015377) Calcium [Moles/volume] in Serum or Plasma

12373

90069

1.50

233.01

3.8

3.6

2.35

2.36

mmol/l

2.04

11119

81468

(3003458) Phosphate [Moles/volume] in Serum or Plasma

5805

35688

1.66

229.31

7.9

5.8

1.05

1.03

mmol/l

8.10

5445

33127

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

11527

82951

1.50

227.88

2.4

2.2

199.33

212.32

u/l

0.87

10936

78174

(36660697) Celiac disease serology panel - Serum

3308

17323

1.89

227.73

1.2

—

(3042936) Bacteria identified in Isolate by Culture

5986

37271

1.64

224.21

2.3

2.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3723

20440

1.81

219.90

4.9

3.8

102.08

91.49

ng/l

8.20

3297

17408

(3020779) Urea [Moles/volume] in Serum or Plasma

4313

24858

1.74

215.24

9.8

7.0

11.10

10.46

mmol/l

5.76

4130

23684

(36304419) Bacteria [Presence] in Urine

9959

70164

1.51

214.41

4.1

3.3

6.55

284.96

estimate

1.12

345

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

2152

9882

2.13

214.11

3.5

824.46

1841.81

u/ml

1.25

1857

8528

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

25737

221403

1.81

212.28

8.7

6.9

40.55

39.91

mmol/mol

26.17

24247

205387

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4622

27247

1.70

212.23

8.7

8.4

119.15

120.94

g/l

7.53

4547

26641

(3014007) Fractional oxyhemoglobin in Arterial blood

3411

18427

1.83

211.84

9.6

9.7

93.74

93.87

0.61

3403

18364

(3014765) Yersinia sp identified in Stool by Organism specific culture

1494

5971

2.42

207.00

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

1492

5983

2.41

205.17

1.3

1.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2949

15408

1.89

203.05

4.7

3.9

24.08

24.23

mmol/l

1.75

2900

15215

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1478

5938

2.41

202.34

1.3

1.2

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3373

18421

1.81

201.48

9.5

1.35

1.31

1.60

3356

18298

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3288

17821

1.82

201.35

9.7

9.8

0.63

0.08

3274

17710

(3003327) Ova and parasites identified in Stool by Light microscopy

1698

7262

2.27

201.28

1.7

1.6

—

(40758558) Short blood count panel - Blood

10453

75191

1.48

198.93

7.6

6.6

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

25826

223337

1.78

195.55

24.0

17.7

75.35

76.89

ml/min/173m2

29.20

24587

208000

(3018418) pH of Serum or Plasma

11051

80769

1.46

191.61

5.5

4.4

7.40

1.93

8074

58178

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

27365

241450

2.15

190.36

17.4

12.9

25.80

25.98

u/l

0.78

26836

233809

(3018677) aPTT in Platelet poor plasma by Coagulation assay

6295

41064

1.56

189.06

2.3

2.0

29.80

29.74

0.33

6130

39958

(3014051) Protein [Presence] in Urine by Test strip

9459

67240

1.47

188.48

3.7

3.1

0.12

0.08

0.79

250

1805

(3020682) Albumin/Creatinine [Ratio] in Urine

12265

91686

1.44

187.18

4.7

4.2

10.85

8.29

mg/mmol

6.94

8187

56301

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

6886

45966

1.53

185.77

2.2

1.9

—

(3009508) Creatinine [Moles/volume] in Urine

12324

92367

1.44

184.54

3.9

3.4

7.30

7.37

mmol/l

1.08

10495

77021

(3000850) Epithelial cells [#/volume] in Urine

8573

60005

1.48

183.60

3.2

2.8

4.50

5.12

e6/l

5.48

7766

54841

(3019150) Specific gravity of Urine by Refractometry

8173

56716

1.49

182.44

5.5

4.3

1.02

1.10

kg/l

1.02

5702

38191

(3012095) Magnesium [Moles/volume] in Serum or Plasma

6766

45165

1.53

181.88

3.8

3.4

0.81

0.82

mmol/l

8.77

6373

42324

(3012516) Albumin [Mass/volume] in Urine

12033

89961

1.44

181.70

4.0

3.5

58.14

46.28

mg/l

6.24

8217

56814

(3020564) Creatinine [Moles/volume] in Serum or Plasma

27551

244185

2.20

181.35

33.9

23.6

84.84

80.11

umol/l

54.23

27312

241243

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

25909

225176

1.75

179.70

6.7

5.6

6.15

6.03

mmol/l

41.21

24024

205432

(3037522) Nuclear Ab [Titer] in Serum

5159

32514

1.59

178.51

1.4

1.3

484.43

521.25

titre

0.80

1111

7221

(3013139) Helicobacter pylori Ag [Presence] in Stool

2940

15945

1.81

178.35

1.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

4023

23964

1.67

174.37

2.6

2.8

65.87

66.23

g/l

2.27

3666

21915

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3056

16876

1.78

174.26

9.5

9.4

24.12

24.31

mmol/l

2.41

2969

16492

(3013512) EKG study

12203

92056

1.42

172.10

4.7

3.8

0.66

0.76

0.68

233

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

7714

53409

1.48

172.10

3.5

3.1

2.46

mmol/l

0.42

6822

47896

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

25038

216160

1.64

171.13

5.2

4.5

1.36

1.29

mmol/l

35.65

23047

196787

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2047

10011

1.99

170.25

1.1

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

5348

34354

1.56

169.33

2.1

1.8

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

3421

19674

1.72

168.73

1.6

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4160

25420

1.62

161.95

1.7

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4745

29928

1.58

161.82

9.8

7.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

26375

231484

1.77

161.23

7.2

6.2

2.53

2.64

mmol/l

72.71

24693

213752

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2647

14360

1.80

159.48

3.4

2.8

1.25

1.21

1.19

2638

14297

(3026782) Osmolality of Urine

7321

50820

1.47

158.70

3.7

3.0

526.70

531.42

mosm/kgh2o

0.33

6380

44741

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2617

14247

1.79

155.65

3.4

2.8

0.63

0.62

0.46

2612

14202

(3004716) Salmonella sp identified in Stool by Organism specific culture

1820

8810

2.00

155.40

1.4

—

(3007461) Platelets [#/volume] in Blood

27622

246455

2.11

154.25

39.9

26.9

246.37

246.50

e9/l

0.12

27270

240829

(3024731) MCV [Entitic mean volume] in Red Blood Cells

27622

246513

2.11

153.15

39.8

26.8

91.61

91.57

0.91

27440

243568

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

27622

246515

2.11

153.11

40.8

27.4

39.55

40.44

27.64

27426

243479

(3026361) Erythrocytes [#/volume] in Blood

27622

246524

2.10

152.94

39.9

26.8

4.39

4.45

e12/l

66.92

27180

239873

(3035941) MCH [Entitic mass]

27620

246500

2.10

152.93

39.7

26.7

30.36

30.43

8.56

27438

243553

(3010813) Leukocytes [#/volume] in Blood

27623

246548

2.10

152.71

39.9

26.9

6.93

6.78

e9/l

17.88

27177

239950

(3000963) Hemoglobin [Mass/volume] in Blood

27623

246550

2.10

152.68

40.2

27.0

131.90

134.46

g/l

138.04

27445

243660

(3020961) Endomysium IgA Ab [Titer] in Serum

1880

9341

1.95

148.71

1.1

117.50

214.56

titre

1.86

257

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

25799

225879

1.65

148.10

6.0

5.3

1.42

1.46

mmol/l

38.89

24052

207858

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

7390

52047

1.45

146.20

4.9

4.1

519.82

458.94

ng/l

0.20

6241

42914

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

25921

227468

1.66

144.17

6.2

5.5

4.43

4.56

mmol/l

75.31

24396

210764

(3017143) Hepatitis C virus Ab [Presence] in Serum

3620

21969

1.62

143.43

1.8

1.6

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3771

23198

1.60

141.11

2.6

2.4

6.43

7.47

ug/l

2.44

3297

20323

(3004119) Hemoglobin [Mass/volume] in Venous blood

2939

17045

1.69

138.75

4.1

3.2

125.52

128.70

g/l

10.98

2867

16575

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1684

8267

1.97

137.68

1.7

1.6

25.34

22.55

u/ml

0.51

306

1714

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4893

32136

1.52

136.37

2.1

1.9

—

(3005719) IgG [Mass/volume] in Serum or Plasma

3138

18656

1.65

134.39

2.9

3.0

10.62

10.65

g/l

0.17

2946

17177

(3028026) IgM [Mass/volume] in Serum or Plasma

2577

14549

1.73

134.07

1.9

2.0

1.36

1.33

g/l

0.23

2392

13265

(3025941) Bacteria identified in Stool by Culture

2198

11886

1.79

132.78

1.4

1.2

—

(3045414) Leukocytes [Presence] in Urine

3944

25036

1.55

127.77

2.4

2.1

0.02

0.01

estimate

0.61

648

4893

(3000494) Fungus identified in Specimen by Culture

4588

30215

1.50

124.99

1.6

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1804

9352

1.86

124.77

3.1

2.9

0.33

0.35

iu/ml

2.93

1008

5157

(3034770) Mitochondria Ab [Titer] in Serum

1371

6478

2.03

124.61

1.3

1.2

851.29

943.57

titre

0.16

196

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1490

7259

1.98

124.24

1.4

1.3

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2445

13901

1.71

123.52

5.2

4.0

48.25

46.77

2.26

2426

13719

(3007566) Smooth muscle Ab [Titer] in Serum

1376

6539

2.02

123.07

1.3

1.2

105.83

134.18

titre

0.81

108

603

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

4622

30750

1.49

119.18

5.6

5.3

32.61

32.68

0.15

3250

19968

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2128

11766

1.75

118.61

2.4

3.70

3.74

g/l

0.52

1907

10702

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2130

11792

1.75

118.17

2.4

4.20

4.21

g/l

0.08

1911

10728

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1618

8245

1.89

117.88

1.4

1.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2131

11810

1.75

117.78

2.4

7.42

7.43

g/l

0.09

1908

10733

(3044889) 12 lead EKG panel

20254

171456

1.36

115.74

5.3

4.4

1.06

2397.82

1.41

378

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2715

16161

1.64

114.63

10.3

9.8

15.68

16.02

8.75

2653

15611

(46235355) HIV 1 and 2 tests - Meaningful Use set

4294

28376

1.49

113.94

1.8

1.7

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1995

10985

1.76

112.61

1.1

3.06

8.87

u/ml

0.73

123

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

829

3333

2.37

112.52

2.9

2.5

167.31

1043.82

u/ml

1.79

819

3295

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1749

9265

1.82

112.52

4.5

3.8

24.71

24.93

mmol/l

2.27

1610

8456

(3002256) Pathology report gross observation

4971

33989

1.45

110.38

1.4

1.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2007

11179

1.73

108.65

1.6

1.5

16.38

15.58

iu/ml

0.06

270

(3020891) Body temperature

2245

12899

1.69

108.45

5.1

4.6

36.90

°c

0.03

2232

12769

(3019225) pH of Specimen

3881

25394

1.50

107.51

5.1

4.3

7.36

0.11

2883

18123

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1849

10129

1.76

106.05

2.4

10.14

10.19

g/l

0.17

1603

8948

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2921

18050

1.58

105.02

4.4

3.6

5.13

5.15

kpa

0.63

2780

17160

(3009343) pH of Capillary blood

2846

17511

1.58

104.19

4.4

3.6

7.41

7.42

4.06

2369

14649

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3514

22667

1.52

103.95

2.4

369.49

381.55

nmol/l

2.91

3245

21044

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1295

6413

1.94

102.58

1.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1977

11143

1.71

102.34

2.4

2.5

2.96

2.90

g/l

1.70

1757

10068

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1838

10152

1.75

102.31

2.5

2.6

0.81

0.93

g/l

0.71

1585

8643

(3017732) Neutrophils [#/volume] in Blood

4572

31206

1.44

101.50

3.2

5.11

4.60

e9/l

1.96

3770

26617

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1428

7331

1.87

101.34

1.5

12.71

15.99

iu/ml

0.34

167

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

3235

20668

1.53

99.81

2.9

61.73

63.24

ml/min/173m2

1.37

1456

8823

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

5987

43075

1.38

97.83

1.4

1.3

29.89

40.39

iu/ml

5.34

1826

13324

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

11534

91456

1.30

97.05

6.3

5.8

2.91

3.51

ug/l

1.08

10486

82574

(3029937) Albumin [Presence] in Urine by Test strip

9561

73938

1.32

96.47

5.3

4.3

0.00

estimate

0.45

2563

25376

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3617

23815

1.49

96.26

1.9

1.7

1.60

1.52

5.90

3057

20479

(3021589) Normoblasts [#/volume] in Blood

13442

108850

1.30

96.12

14.4

12.3

0.00

e9/l

1.49

10939

88656

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2509

15264

1.59

95.97

4.1

3.5

1.49

1.93

mmol/l

7.06

1893

11338

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

12161

97287

1.30

95.00

5.2

4.1

1.41

0.55

estimate

1.02

2290

22745

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1707

9435

1.74

94.58

1.3

—

(3037121) Protein [Mass/volume] in Urine

1585

8675

1.76

90.82

3.2

639.79

520.74

mg/l

0.33

748

3877

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1780

10073

1.70

90.45

2.4

2.2

474.11

591.40

ug/l

0.90

1689

9599

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

5565

40045

1.38

89.70

1.3

13.72

12.89

u/ml

0.22

1917

15014

(3027273) Bicarbonate [Moles/volume] in Venous blood

2118

12577

1.63

89.28

4.5

3.5

25.05

25.30

mmol/l

2.66

2068

12197

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2762

17452

1.54

89.06

7.3

7.0

24.52

24.57

mmol/l

0.31

2676

16728

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1549

8507

1.75

87.63

2.5

2.4

0.03

g/l

0.08

1395

7624

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

538

1992

2.56

87.19

1.3

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3381

22378

1.47

86.95

2.9

2.5

0.44

0.45

e6/l

0.08

3274

21470

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1418

7609

1.79

86.88

2.6

2.5

0.00

g/l

-0.00

1308

7122

(3000492) Spirometry study

3314

21931

1.47

85.17

1.7

1.5

—

17.05

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1547

8572

1.73

84.73

1.9

1.6

0.33

0.32

mg/l

0.23

760

4115

(3018405) Lactate [Moles/volume] in Arterial blood

1592

8928

1.71

83.46

4.2

1.39

mmol/l

0.05

1563

8748

(4035726) Immunohistochemistry procedure

3465

23256

1.45

82.56

1.4

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2791

18025

1.50

80.72

9.2

7.8

24.70

24.81

mmol/l

0.77

2771

17883

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1751

10175

1.65

80.18

3.1

3.5

38.71

45.71

mg/l

2.25

1571

8577

(3034860) Kappa light chains.free [Mass/volume] in Serum

1752

10192

1.65

79.87

3.1

3.5

64.90

70.64

mg/l

0.22

1573

8588

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1712

9903

1.66

79.79

2.8

2.7

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1473

8198

1.72

79.30

2.5

0.00

g/l

0.12

1309

7142

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1319

7170

1.76

77.15

1.5

16.90

6.54

iu/ml

0.37

268

1428

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

21319

185451

1.30

76.88

34.5

23.0

330.65

331.84

g/l

66.47

21226

184424

(3043409) Potassium [Moles/volume] in Arterial blood

1357

7451

1.74

76.63

4.4

4.5

3.86

3.90

mmol/l

2.37

1346

7383

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3302

22387

1.43

73.89

3.4

3.0

231.87

216.11

ng/l

1.05

3027

20646

(3024980) IgG subclass 4 [Mass/volume] in Serum

829

3967

1.99

72.32

1.8

1.6

0.69

0.83

g/l

3.79

668

3052

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1133

6015

1.80

71.77

3.2

3.4

152.46

1174.28

u/ml

6.12

1031

5442

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1143

6105

1.79

70.93

1.4

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1555

9062

1.64

70.18

3.1

3.4

3.83

5.97

ratio

0.70

983

5215

(3024928) Oxygen saturation in Venous blood

1232

6762

1.74

69.57

3.4

3.0

61.38

61.29

0.05

1180

6522

(3023183) Ammonium ion [Moles/volume] in Plasma

1099

5857

1.79

68.69

3.4

2.5

35.05

33.19

umol/l

1.46

984

5239

(3005988) Vibrio sp identified in Specimen by Organism specific culture

675

3070

2.09

67.71

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

673

3066

2.08

67.21

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

667

3064

2.07

65.15

1.5

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

2177

13970

1.50

64.25

1.4

1.3

239.83

242.42

u/ml

0.03

2005

12997

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

9169

73257

1.25

64.13

5.1

4.7

22.08

22.12

0.09

4897

37824

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

973

5141

1.80

62.55

1.1

5.71

8.41

eliau/ml

0.74

531

(3003129) Base excess in Capillary blood by calculation

685

3237

2.01

61.91

2.7

2.2

0.35

0.50

mmol/l

0.45

662

3119

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2280

14897

1.47

61.41

1.5

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

684

3244

2.00

61.20

1.2

1.1

1.55

1.54

g/l

0.24

620

2957

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

295

972

2.87

60.10

1.1

1.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

679

3234

1.99

60.03

1.5

1.4

—

(3049717) Cytology report of Urine Cyto stain

1776

11077

1.54

59.82

2.9

2.8

—

(3045424) Erythrocytes [Presence] in Urine

1989

12716

1.50

59.62

2.5

2.1

0.58

0.10

estimate

0.39

438

3782

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

690

3317

1.97

59.41

1.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

678

3246

1.98

59.06

1.5

1.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2249

14798

1.46

58.30

1.3

50.34

55.89

au/ml

0.57

139

983

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2420

16156

1.44

58.08

2.5

2.4

22.66

23.39

au/ml

0.13

195

1545

(3036489) Thrombin time

1485

8957

1.59

57.96

2.1

1.9

21.50

21.36

0.27

1350

8009

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1690

10509

1.54

57.66

2.0

1.9

39.60

39.31

u/l

0.23

1463

9173

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1251

7261

1.64

57.17

2.6

2.4

3.70

3.61

g/l

1.20

1206

6951

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

7012

54958

1.26

56.26

1.8

35168784.68

31239285.15

pmol/l

0.22

5940

44832

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

631

3006

1.99

55.76

3.5

6.33

10.50

nmol/l

0.87

617

2919

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1031

5734

1.71

55.40

1.7

1.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1259

7379

1.63

55.32

1.7

1.6

1.20

1.19

g/l

0.10

1210

7044

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1832

11718

1.50

54.64

2.1

1.9

1.74

2.23

ug/l

1.91

1631

10371

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1224

7171

1.63

53.85

1.7

1.6

0.24

g/l

0.05

1172

6815

(3037756) Immunofixation for Serum or Plasma

1092

6242

1.67

52.94

1.6

1.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1811

11654

1.49

52.37

5.6

5.2

0.87

0.24

1740

11047

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1144

6639

1.64

52.27

2.5

2.4

206.20

202.10

0.79

1081

6288

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1216

7173

1.62

52.02

2.3

2.1

91.61

90.93

0.47

1175

6901

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

950

5256

1.72

52.01

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

950

5256

1.72

52.01

1.4

1.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

950

5282

1.71

51.09

6.9

5.4

811.81

1134.93

iu/ml

0.33

159

806

(3023420) DNA double strand Ab [Units/volume] in Serum

1564

9873

1.51

49.58

1.7

6.64

7.56

iu/ml

0.65

365

2324

(3052851) Hemolysis interference index of Serum or Plasma

1215

7257

1.60

49.33

3.9

3.3

2.26

2.13

index

0.25

653

3627

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

360

1444

2.36

49.24

1.3

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

356

1425

2.36

48.92

1.3

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

849

4648

1.73

48.27

1.2

—

(3044927) Protein electrophoresis panel - Urine

569

2762

1.95

47.68

1.2

—

(3003694) ABO and Rh group [Type] in Blood

7990

64493

1.22

47.18

1.4

1.3

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

422

1842

2.17

47.18

1.2

98.00

160.77

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

422

1846

2.16

46.92

1.2

137.82

183.25

titre

0.65

317

(40768443) Skin Pathology biopsy report

1800

11912

1.44

44.88

1.3

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1916

12838

1.43

44.64

5.4

4.9

1.65

1.60

1.21

1846

12210

(21494890) Protein electrophoresis panel - 24 hour Urine

589

2960

1.88

44.49

1.9

2.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1015

5977

1.61

43.68

3.7

3.3

0.79

0.81

nmol/l

0.43

825

4822

(4062490) Immunoglobulin typing, IgG

500

2399

1.97

43.37

1.5

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

6772

54151

1.23

43.02

3.5

3.3

0.76

0.79

ug/l

1.05

4935

37093

(3000475) Leukocytes [#/volume] in Synovial fluid

1136

6902

1.57

42.81

1.7

1.6

15986.16

14042.47

e6/l

0.61

800

4913

(1761482) Bacteria [#/volume] in Urine by Culture

1079

6489

1.58

42.51

5.3

4.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1042

6242

1.59

41.74

1.3

7.79

13.58

u/ml

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1522

9899

1.47

41.50

3.2

3.0

24.51

24.84

mmol/l

2.64

1500

9720

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2097

14451

1.39

41.46

3.3

3.5

4.38

4.41

pmol/l

0.68

1842

12924

(3024139) IgG subclass 3 [Mass/volume] in Serum

501

2457

1.93

40.78

1.5

1.4

0.41

0.43

g/l

0.29

388

1747

(3028192) IgG subclass 2 [Mass/volume] in Serum

501

2458

1.93

40.74

1.5

1.4

2.82

2.95

g/l

0.94

386

1747

(3027135) IgG subclass 1 [Mass/volume] in Serum

501

2460

1.93

40.64

1.5

1.4

6.60

6.90

g/l

1.16

387

1749

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

746

4137

1.71

40.51

1.3

1.2

43.17

58.79

u/ml

—

(3038515) Glucose [Moles/volume] in Venous blood

961

5690

1.60

40.43

4.6

3.4

7.70

7.60

mmol/l

0.46

943

5561

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

618

3249

1.80

40.43

2.6

2.0

24.91

27.16

mg/l

0.52

230

1202

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

21127

187801

1.20

40.21

32.0

21.8

14.03

13.76

130.06

20966

185326

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1196

7454

1.53

40.16

1.5

1.4

—

(4024509) Urine culture

1793

12093

1.42

40.16

2.1

2.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

616

3243

1.80

40.12

1.3

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

230

827

2.62

39.82

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1019

6160

1.57

39.25

2.5

2.3

117.98

111.56

ug/min

0.19

603

3534

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

856

4963

1.64

39.23

1.3

283.92

269.05

titre

0.06

401

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

490

2421

1.91

39.03

3.4

2.7

—

(3000330) Specific gravity of Urine by Test strip

1935

13294

1.39

38.89

4.7

3.5

1.02

ratio

0.01

1755

12039

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

857

4986

1.63

38.74

1.3

166.25

136.91

titre

0.14

(3042733) HLA Ab [Presence] in Serum

204

700

2.75

38.72

5.5

4.9

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

916

5431

1.60

38.32

1.3

1.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

253

975

2.45

37.94

42.3

38.5

7.07

7.19

ug/l

0.44

227

862

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1088

6747

1.53

37.38

1.3

2.64

5.81

u/ml

1.86

657

(1761868) Lipid panel - Serum or Plasma

7828

83343

0.84

37.04

3.7

3.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1143

7195

1.51

36.60

1.3

31.30

41.62

u/ml

0.64

378

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

962

5835

1.57

36.51

1.3

1.2

2.63

5.17

u/ml

1.06

407

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

690

3861

1.69

36.28

1.3

297.19

274.52

u/ml

1.01

444

2396

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1082

6746

1.52

36.26

1.3

7.14

6.63

u/ml

0.10

141

1025

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

516

2677

1.82

35.32

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

766

4456

1.63

34.66

1.6

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

490

2517

1.84

34.64

1.7

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

761

4423

1.63

34.56

1.5

1.4

34.73

20.18

u/ml

1.88

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

338

1539

2.07

34.01

1.8

326.71

355.96

mu/l

0.67

274

1210

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

690

3933

1.66

33.84

7.2

6.0

12.22

12.09

mg/l

0.30

628

3648

(3008037) Lactate [Moles/volume] in Venous blood

1081

6852

1.50

33.48

4.5

3.2

1.59

mmol/l

0.03

1062

6695

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1368

9102

1.43

32.96

1.3

1.2

0.63

0.88

u/ml

0.49

141

757

(3020876) Protein [Mass/time] in 24 hour Urine

629

3530

1.69

32.74

2.2

2.5

1.17

g/24h

0.02

377

2086

(40757494) Bilirubin.total [Moles/volume] in Blood

293

1287

2.15

32.41

2.4

2.1

17.53

27.89

umol/l

1.13

110

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

962

6004

1.52

32.08

1.5

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

587

3253

1.71

32.03

1.6

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

587

3254

1.71

31.99

1.6

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

587

3254

1.71

31.99

1.6

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

587

3254

1.71

31.99

1.6

1.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

529

2849

1.76

31.97

1.2

54.77

63.06

u/l

2.38

472

2480

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

11907

102007

1.16

31.78

2.0

1.39

1.34

mmol/l

7.02

10099

83792

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

512

2737

1.77

31.75

4.1

3.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

668

3841

1.65

31.69

1.1

—

(40768441) Liver Pathology biopsy report

370

1789

1.95

31.52

1.7

1.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

704

4113

1.62

31.34

3.1

2.5

982.03

6085.54

u/ml

1.37

258

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

682

3967

1.63

30.91

1.6

1.4

157.14

154.14

au/ml

0.25

173

1195

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1085

7001

1.47

30.75

1.7

1.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1040

6695

1.47

29.83

2.2

2.0

13.08

11.87

mg/l

5.05

969

6225

(3000093) Morphology [Interpretation] in Blood Narrative

485

2600

1.76

29.81

1.2

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1523

10503

1.38

29.77

2.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

455

2401

1.79

29.52

1.1

3.73

3.71

eliau/ml

0.01

148

980

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

293

1346

2.05

28.87

2.2

2.5

980.66

1205.82

u/ml

0.90

288

1324

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

829

5135

1.53

28.66

1.5

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1138

7528

1.43

28.28

3.5

2.8

1.83

1.64

mg/l

10.14

1057

6769

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1409

9686

1.38

28.06

1.9

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

790

4872

1.54

27.88

1.5

—

(4146454) Self-monitoring of blood glucose

542

3056

1.68

27.79

2.9

2.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

968

6232

1.47

27.76

1.6

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

352

1749

1.90

27.72

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

347

1719

1.90

27.58

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

266

1212

2.07

26.84

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

266

1212

2.07

26.84

1.5

1.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

325

1595

1.92

26.59

1.2

35.81

26.15

u/l

1.05

269

1331

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

627

3711

1.60

26.51

1.4

1.3

0.19

0.24

nmol/l

0.71

291

(3004616) Nuclear Ab [Presence] in Serum

543

3103

1.65

26.46

1.3

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

352

1779

1.87

26.33

1.1

289.04

290.28

mg/l

0.12

310

1615

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

500

2808

1.68

26.05

1.4

1.2

28.16

54.75

u/ml

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

626

3723

1.59

25.95

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

329

1639

1.89

25.74

1.3

1.2

111.94

93.65

u/l

1.32

277

1400

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

613

3637

1.59

25.67

1.4

1.3

1.99

1.95

nmol/l

0.01

584

3510

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2695

20545

1.25

25.26

2.5

2.3

12.27

13.08

nmol/l

5.46

2354

18358

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

215

926

2.19

25.12

2.9

2.7

0.60

0.61

mmol/l

1.75

215

926

(3009214) Lutropin [Units/volume] in Serum or Plasma

742

4620

1.52

25.08

1.4

11.64

11.51

u/l

0.08

595

3696

(3026389) Candida sp identified in Specimen by Organism specific culture

588

3485

1.59

24.75

1.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

225

996

2.13

24.54

35.4

30.8

112.71

111.43

ug/l

0.12

185

833

(3024891) Influenza virus A+B Ag [Presence] in Specimen

843

5419

1.47

24.39

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

279

1340

1.96

24.37

1.5

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

761

4793

1.50

24.36

1.3

35.86

35.47

u/l

0.03

664

4146

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

279

1341

1.96

24.32

1.5

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

614

3692

1.57

24.31

1.5

1889.54

3378.26

e6/l

2.26

426

2618

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

263

1242

2.00

24.11

2.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

344

1777

1.83

24.05

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

457

2561

1.68

24.05

1.4

191743.85

125722.78

e6/l

0.89

307

1691

(21494434) Karyotype in Bone marrow

440

2443

1.70

23.96

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

224

1019

2.07

22.79

2.6

1.9

3290.91

3148.19

e6/l

0.02

159

672

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

780

5015

1.47

22.57

1.9

1.7

0.90

0.86

nmol/l

0.79

659

4215

(3036603) Volume of Urine

365

1958

1.76

22.52

1.7

1.6

1912.77

1919.61

0.05

352

1908

(3021788) Differential panel - Synovial fluid

805

5213

1.46

22.45

1.6

1.5

0.88

1.00

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

468

2688

1.64

22.43

1.2

43.31

43.22

u/ml

0.00

142

(3005570) Glucose [Moles/volume] in Urine

431

2429

1.67

22.24

1.8

2.0

—

1.29

—

(3010838) Calcium [Moles/time] in 24 hour Urine

726

4621

1.49

22.11

1.9

4.72

4.97

mmol/24h

1.29

644

4061

(3024471) HLA-A [Type]

167

684

2.30

22.09

1.0

—

(3024932) HLA-DR beta [Type]

164

667

2.31

22.05

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

671

4206

1.51

22.02

1.5

31.14

39.89

g/l

0.65

589

3831

(3028308) Erythrocytes [#/volume] in Pleural fluid

548

3287

1.57

21.97

1.5

62137.87

55462.85

e6/l

0.18

318

1873

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

530

3159

1.58

21.84

1.3

1.2

3.89

3.97

u/ml

0.05

254

1468

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

787

5112

1.46

21.62

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

788

5120

1.46

21.61

1.3

1.2

36.85

47.34

u/ml

0.88

490

(3022621) pH of Urine by Test strip

2570

19847

1.24

21.28

3.2

2.7

6.04

0.03

1664

13834

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1015

6920

1.39

21.27

1.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

519

3098

1.58

21.26

1.4

1.3

—

nmol/l

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

965

6542

1.40

20.92

2.0

1.8

42.85

43.68

nmol/l

0.53

932

6356

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

531

3209

1.56

20.64

1.4

1.3

0.19

0.22

nmol/l

1.47

422

2567

(3017181) Myelocytes/Leukocytes in Blood

3033

23914

1.21

20.44

4.9

4.3

0.93

0.96

0.27

1052

7526

(3003181) Sodium [Moles/volume] in Urine

811

5359

1.43

20.34

1.4

59.51

60.99

mmol/l

0.51

655

4285

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

823

5454

1.43

20.32

1.1

1.2

4.98

3.26

0.82

601

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

250

1237

1.90

20.10

2.4

1.9

91.35

98.20

2.04

239

1169

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

301

1579

1.80

20.10

1.4

13.65

13.56

umol/l

0.07

284

1483

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1550

11351

1.30

20.06

1.9

1.8

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

786

5189

1.43

19.83

2.0

1.9

187.97

200.41

pmol/l

2.96

720

4889

(3011985) Renin [Units/volume] in Plasma

594

3713

1.51

19.80

1.4

70.78

59.66

mu/l

0.56

526

3322

(3032057) Clostridioides difficile [Presence] in Stool

129

497

2.44

19.63

1.9

1.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

681

4384

1.47

19.63

1.4

1.5

11.35

14.85

u/ml

0.47

100

(3026692) Albumin [Mass/volume] in Peritoneal fluid

168

727

2.17

19.53

1.7

1.3

13.31

13.58

g/l

0.15

129

552

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

289

1513

1.80

19.45

1.1

—

0.49

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

564

3508

1.52

19.26

1.2

16.27

11.67

u/ml

0.17

142

(3017704) Immunofixation for Urine

294

1553

1.78

19.21

1.4

1.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

332

1818

1.72

19.13

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

191

877

2.05

19.05

2.4

1.8

8808.29

12660.04

e6/l

0.35

108

451

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1415

10310

1.30

19.03

1.9

1.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

362

2035

1.68

18.94

2.4

2.3

25.34

25.66

iu/ml

0.02

281

(3051611) Lipemic interference index of Serum or Plasma

446

2643

1.59

18.91

3.8

3.5

13.31

13.78

index

0.23

277

1407

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

528

3258

1.53

18.73

1.3

1.2

3.06

4.21

u/ml

1.00

200

1227

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

443

2633

1.59

18.55

2.1

2.0

1536.52

3578.38

u/l

2.11

126

954

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

285

1511

1.78

18.41

1.2

86.52

82.65

0.74

111

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1584

11760

1.28

18.41

3.1

4.1

47.49

69.24

u/ml

2.74

1522

11358

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

191

889

2.02

18.38

1.7

1.8

13678.43

29057.73

u/ml

0.44

135

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

392

2269

1.63

18.32

1.2

80.90

82.76

u/ml

—

(3002179) Metamyelocytes/Leukocytes in Blood

2872

22752

1.20

18.32

4.6

4.2

0.70

0.72

0.16

1035

7143

(3042111) Morphology [Interpretation] in Bone marrow Narrative

710

4674

1.44

18.22

1.5

1.6

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

243

1233

1.86

18.13

1.2

1.1

3.07

4.47

iu/ml

1.26

(3006270) Folate [Moles/volume] in Blood

345

1941

1.68

18.03

1.3

1.2

319.86

350.61

nmol/l

2.01

274

1585

(3006462) Nitrate [Presence] in Urine

219

1078

1.91

17.95

4.6

3.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1115

7931

1.33

17.83

1.8

1.7

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

234

1180

1.87

17.82

1.6

10.29

9.38

ug/l

0.18

224

1081

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

563

3563

1.49

17.73

1.2

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

403

2370

1.60

17.67

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1812

13746

1.25

17.56

1.2

110.72

135.91

u/ml

2.48

659

5006

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

278

1485

1.76

17.53

2.4

2.5

241.01

234.87

e6/l

0.17

243

1300

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

271

1441

1.77

17.37

2.3

2.4

485.55

535.53

e6/l

0.49

223

1184

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

544

3437

1.49

17.29

1.3

310.97

324.26

pmol/l

0.15

461

2904

(3013005) Retinol [Moles/volume] in Serum or Plasma

190

908

1.97

17.02

1.9

1.5

2.01

2.00

umol/l

0.06

179

828

(40768446) Kidney Pathology biopsy report

192

923

1.96

16.91

1.7

1.6

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

123

498

2.32

16.84

1.2

—

(3017354) Segmented neutrophils/Leukocytes in Blood

491

3056

1.52

16.78

3.4

3.6

59.21

57.90

0.72

422

2609

(3045788) Cell count panel - Pleural fluid

481

2988

1.52

16.60

1.5

—

(3039000) Anion gap in Blood by calculation

832

5725

1.37

16.55

7.0

6.8

11.15

11.24

mmol/l

0.32

768

5182

(3018572) Chloride [Moles/volume] in Blood

832

5726

1.37

16.53

7.0

6.8

105.12

104.96

mmol/l

0.41

768

5184

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

129

541

2.24

16.29

1.2

309.36

280.44

pmol/l

0.21

394

(4211845) Urine protein measurement

229

1182

1.82

16.24

4.5

3.1

—

(21494755) Public health laboratory ask at order entry panel

1244

14833

0.78

16.21

1.4

—

(3021440) Promyelocytes/Leukocytes in Blood

2856

22878

1.19

16.03

5.0

4.4

0.11

0.12

0.34

881

6529

(3025159) Blasts/Leukocytes in Blood

2869

22992

1.19

16.02

5.1

4.5

0.13

0.34

2.85

872

6206

(3018851) Theophylline [Moles/volume] in Serum or Plasma

219

3.00

16.01

1.6

54.60

44.69

umol/l

1.27

219

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

289

1606

1.69

15.88

1.6

1.5

6.50

7.20

u/l

0.34

233

1267

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

366

2169

1.59

15.61

1.2

—

(3008898) HLA-B27 [Presence]

866

6076

1.35

15.24

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

367

2194

1.58

15.10

1.5

1.6

23.67

25.61

u/ml

0.35

428

(3002331) Protein [Mass/volume] in Peritoneal fluid

144

651

2.08

15.09

1.4

26.22

37.77

g/l

0.67

110

504

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

885

6240

1.34

15.08

1.8

1.9

12.08

13.75

iu/l

0.07

293

2411

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

706

4805

1.39

15.06

1.7

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

361

2154

1.58

14.98

1.4

1.3

32.08

34.58

u/l

0.65

282

1758

(3018333) Ribosomal P Ab [Presence] in Serum

303

1733

1.65

14.96

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

457

2873

1.50

14.95

1.4

1.3

360.47

486.87

u/l

1.41

429

2726

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

329

1926

1.61

14.80

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

635

4259

1.41

14.77

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

203

1042

1.83

14.71

1.0

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

387

2357

1.55

14.69

1.2

1.1

2.03

1.92

iu/ml

0.05

(3020717) Zinc [Moles/volume] in Serum or Plasma

228

1215

1.77

14.60

1.6

1.4

21.24

23.28

umol/l

0.51

216

1111

(40759836) Histone Ab [Presence] in Serum by Immunoblot

323

1890

1.61

14.57

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

306

1768

1.63

14.53

1.2

—

(3004775) Volume in Urine collected for unspecified duration

346

2060

1.58

14.51

2.6

2.2

723.23

672.55

1.29

243

1357

(40768806) Pleura Pathology biopsy report

494

3175

1.47

14.49

1.5

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

313

1820

1.62

14.48

1.3

63.33

73.56

titre

0.19

135

(3039162) Centromere protein B Ab [Units/volume] in Serum

470

2992

1.48

14.47

1.3

54.97

60.57

u/ml

0.17

187

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

194

990

1.84

14.34

1.9

1.5

28.08

29.51

umol/l

1.04

185

930

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

380

2321

1.54

14.25

1.7

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

380

2321

1.54

14.25

1.7

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

380

2321

1.54

14.25

1.7

1.6

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

215

1139

1.78

14.07

1.2

—

(4268621) Lupus anticoagulant assay

364

2211

1.55

14.01

2.4

2.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

397

2461

1.52

13.92

1.5

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

314

1847

1.60

13.88

1.2

—

(3044007) Cell count panel - Peritoneal fluid

174

867

1.89

13.88

2.4

1.8

—

(3036782) Glucose [Moles/volume] in Pleural fluid

450

2868

1.48

13.80

1.4

1.3

6.84

6.27

mmol/l

3.29

412

2682

(3016244) Insulin [Units/volume] in Serum or Plasma

188

962

1.84

13.80

2.6

3.0

28.64

23.73

mu/l

0.85

179

894

(3036670) Protein [Mass/volume] in Synovial fluid

169

836

1.90

13.78

1.3

39.48

40.53

g/l

0.42

422

(3004809) Band form neutrophils/Leukocytes in Blood

681

4680

1.37

13.73

3.6

1.45

1.58

0.43

600

4175

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

313

1845

1.60

13.72

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

307

1806

1.60

13.58

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

414

2604

1.50

13.56

1.4

1.3

1.50

1.44

nmol/l

0.51

379

2352

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

316

1875

1.59

13.49

1.3

190.48

550.46

titre

2.29

153

(37021550) Renin [Units/volume] in Plasma --upright

109

467

2.19

13.17

1.2

80.59

63.88

mu/l

0.32

337

(40762887) Creatinine [Moles/volume] in Blood

188

2.95

13.15

1.6

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

171

864

1.86

13.10

1.2

—

(4195642) Thrombophilia screening test

458

2963

1.46

13.04

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

143

683

1.97

12.96

1.6

2.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

421

2683

1.48

12.95

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

600

4079

1.39

12.95

1.1

1.2

0.68

0.98

0.72

109

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

124

566

2.06

12.75

2.8

2.4

234.52

474.83

ug/l

0.35

124

566

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

210

1141

1.73

12.65

1.8

2.1

39.34

40.13

g/l

1.09

210

1141

(4015189) Microbial culture of sputum

143

690

1.95

12.60

2.2

—

(3029075) Extractable nuclear Ab panel - Serum

250

1426

1.65

12.57

1.1

—

0.37

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

236

1327

1.67

12.54

1.2

385.63

319.58

u/l

0.19

216

1237

(3020191) Ethanol [Moles/volume] in Serum or Plasma

314

1894

1.56

12.53

1.4

1.23

1.20

promille

0.11

252

1486

(3019832) Treponema pallidum Ab [Presence] in Serum

1308

9941

1.25

12.50

1.6

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

267

1551

1.62

12.49

2.4

2.5

0.66

0.65

e9/l

0.04

252

1467

(3047181) Lactate [Moles/volume] in Blood

1112

8309

1.27

12.32

6.4

5.8

1.26

1.33

mmol/l

2.14

998

7379

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

136

651

1.96

12.28

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

118

538

2.06

12.20

3.5

3.3

7.53

8.08

mg/l

0.38

108

428

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

344

2132

1.52

12.15

1.5

1.4

13.51

13.14

u/l

0.48

334

2054

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

642

4462

1.36

12.11

2.1

1.9

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

415

2675

1.46

12.09

2.3

2.1

1.92

7.05

titre

1.47

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

221

1234

1.69

12.07

2.1

2.2

91.73

111.55

ug/min

0.18

273

(3033099) Centromere Ab [Titer] in Serum

128

605

1.99

12.00

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

562

3831

1.38

11.97

1.7

1.9

25.99

25.94

ug/l

0.00

552

3755

(3034274) Bile acid [Moles/volume] in Serum --fasting

230

1301

1.66

11.97

1.6

8.47

11.58

umol/l

1.23

167

940

(3045142) Bone marrow Pathology biopsy report

475

3146

1.42

11.96

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

468

3095

1.43

11.89

1.1

—

(40761536) Microorganisms panel - Urine sediment

1801

19974

0.84

11.80

5.3

4.3

—

(3038026) Centromere Ab [Units/volume] in Serum

317

1944

1.54

11.78

1.2

41.84

60.58

u/ml

0.62

115

(3027923) C peptide [Moles/volume] in Serum or Plasma

252

1466

1.62

11.75

1.5

1.3

1.29

1.26

nmol/l

0.13

179

1094

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

317

2.37

11.66

5.2

5.6

765.67

11615.65

iu/ml

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

451

2986

1.42

11.41

1.2

1.1

119.79

116.99

0.97

416

2684

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

401

2599

1.45

11.38

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

359

2277

1.48

11.38

1.3

10.95

14.36

u/l

2.67

333

2095

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

363

2313

1.48

11.25

1.2

1.1

96.49

96.28

0.05

340

2155

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

520

3542

1.38

11.17

1.1

65.03

3763.31

iu/ml

0.58

672

(3008401) Mugwort IgE Ab [Units/volume] in Serum

408

2666

1.44

11.10

1.1

0.72

0.98

u/ml

0.75

166

1100

(44813793) Dust mix specific IgE antibody measurement

252

1488

1.59

11.08

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

383

5137

0.70

11.07

1.1

0.63

0.62

ratio

0.09

875

(3023419) Bacteria identified in Sputum by Culture

538

3693

1.37

11.03

2.8

2.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

748

5395

1.31

10.98

2.2

1.9

—

(3001186) Copper [Moles/volume] in Serum or Plasma

120

573

1.97

10.97

1.3

1.2

16.87

16.37

umol/l

0.63

108

500

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

100

447

2.10

10.94

2.0

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

345

2191

1.48

10.89

1.8

1.6

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

204

1148

1.67

10.88

7.7

3.8

1694.57

1375.45

mg/l

0.10

159

799

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

215

1227

1.65

10.86

1.4

—

(3047189) Immunofixation for 24 hour Urine

231

1351

1.61

10.60

1.6

1.8

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

270

1638

1.55

10.59

1.9

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

927

6909

1.27

10.55

2.5

2.3

126.52

128.94

g/l

2.02

658

5300

(3003888) Timothy IgE Ab [Units/volume] in Serum

417

2765

1.42

10.50

1.1

2.75

3.24

u/ml

0.49

209

1330

(4094501) Cardiovascular stress test using bicycle ergometer

963

7214

1.26

10.50

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

485

3301

1.38

10.50

1.1

1.62

1.46

u/ml

0.12

255

1759

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

100

455

2.07

10.47

2.0

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

240

1421

1.59

10.47

1.5

6.22

5.96

u/l

0.13

197

1221

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

617

4365

1.33

10.42

1.3

209.43

211.99

miu/ml

0.05

219

1721

(3021387) Prolactin [Units/volume] in Serum or Plasma

642

4574

1.32

10.32

1.8

284.63

293.30

mu/l

0.29

600

4198

(3035320) C reactive protein [Mass/volume] in Body fluid

311

1959

1.49

10.25

2.6

2.8

27.40

30.71

mg/l

0.81

225

1437

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

356

2305

1.45

10.22

1.8

1140.00

2922.20

titre

0.98

(3028433) Virus identified in Specimen by Culture

145

755

1.81

10.21

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

186

1042

1.68

10.13

1.5

1.7

2.67

7.11

nmol/l

1.22

154

882

(3020911) Cortisol [Moles/time] in 24 hour Urine

146

769

1.78

9.91

1.3

1.4

267.31

213.85

nmol/24h

0.11

146

769

(3041096) Erythrocytes [Presence] in Urine by Automated

7763

68130

1.09

9.85

4.3

3.6

0.73

0.27

estimate

1.08

2199

21953

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

104

492

1.99

9.82

2.8

2.4

125.05

159.02

au/ml

0.32

(3000034) Microalbumin [Mass/volume] in Urine

343

2226

1.45

9.75

3.5

2.9

59.75

45.71

mg/l

0.36

251

1593

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

152

2.84

9.71

2.2

2.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

130

666

1.83

9.67

2.7

3.0

2.10

1.82

ratio

0.93

118

607

(3020491) Glucose [Moles/volume] in Blood

270

1673

1.52

9.66

1.6

1.9

7.19

7.20

mmol/l

0.03

166

1180

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

246

1495

1.55

9.62

3.2

2.0

18.04

16.08

nmol/l

3.31

235

1388

(3011412) CD3 cells [#/volume] in Blood

342

2225

1.45

9.60

2.4

2.3

1110.31

1142.66

e6/l

0.20

303

2011

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

824

6128

1.27

9.59

1.3

574.37

581.25

mg/l

0.07

785

5866

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

274

1710

1.51

9.49

1.5

1.3

1.30

1.41

u/ml

0.11

175

999

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

3.45

9.32

1.0

29.71

21.18

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

3.45

9.32

1.0

36.40

30.85

u/ml

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

232

1404

1.55

9.27

2.8

39.06

37.46

0.61

135

771

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

196

1140

1.62

9.27

1.2

—

(3014271) Vancomycin [Susceptibility]

230

1393

1.55

9.16

3.1

3.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3374

28467

1.13

9.09

1.5

1.4

—

(3023383) Lactate [Moles/volume] in Pleural fluid

160

889

1.69

9.04

1.5

1.3

3.44

3.53

mmol/l

0.12

149

817

(3006571) Granulocytes/Leukocytes in Synovial fluid

478

3331

1.35

9.00

1.6

1.5

60.11

59.33

0.17

336

2063

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

107

529

1.90

8.93

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

130

684

1.79

8.91

1.7

2.2

204.49

189.32

0.71

125

646

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

120

618

1.82

8.83

8.8

6.5

63.52

71.18

2.26

489

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

150

826

1.71

8.78

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

469

3275

1.35

8.73

1.1

23.70

16.07

au/ml

0.69

664

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

220

1339

1.55

8.61

1.2

1.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

733

5451

1.27

8.58

1.3

3.83

3.81

mmol/l

0.18

688

5182

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

138

748

1.73

8.56

2.1

1.9

29.43

30.54

0.39

132

701

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

133

716

1.75

8.46

1.1

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

136

742

1.72

8.26

1.3

1.2

0.31

g/l

0.09

110

605

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

126

673

1.76

8.24

1.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

491

1.89

8.23

1.8

1.6

97.94

112.64

ug/l

0.82

403

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

363

2.04

8.16

1.3

42.90

41.86

mg/l

0.06

305

(3006245) CD3-CD19+ cells/cells in Blood

135

738

1.72

8.15

2.2

2.0

9.36

10.19

0.32

126

668

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

3.36

8.14

1.1

207.68

186.12

ug/g

0.18

(3026051) Granulocytes/Leukocytes in Pleural fluid

121

642

1.77

8.11

1.5

1.4

20.15

22.56

0.50

103

534

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

174

1019

1.61

8.07

2.2

2.0

55.83

57.77

ug/l

0.14

174

995

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

244

1541

1.49

8.06

1.2

1.1

90.24

83.88

u/l

0.65

221

1358

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

304

2006

1.43

8.00

1.2

109.97

107.03

pmol/l

0.25

304

2006

(3020393) Adenovirus Ag [Presence] in Stool

203

2.41

7.97

1.2

1.1

—

(3011436) Histone Ab [Units/volume] in Serum

101

512

1.85

7.87

1.0

1.1

—

21.20

u/ml

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

337

2274

1.39

7.82

1.7

1.9

3.83

4.12

mg/l

0.77

322

2183

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

126

691

1.71

7.56

1.5

1.6

0.41

0.38

ug/l

0.37

485

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

127

699

1.71

7.52

1.3

1.2

110.09

112.30

0.34

107

624

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

240

1534

1.47

7.51

1.2

1.1

27.68

24.25

u/l

0.43

217

1347

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

481

3453

1.31

7.47

1.6

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

139

786

1.66

7.45

1.5

15.83

15.59

pmol/l

0.10

124

643

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

239

1529

1.47

7.45

1.9

1.8

—

(3016038) Potassium [Moles/volume] in Urine

284

1879

1.42

7.40

1.3

1.1

33.33

34.44

mmol/l

0.34

253

1613

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

290

1926

1.42

7.40

4.8

5.6

95.48

107.04

u/ml

0.08

616

(3041672) Baker's yeast Ab [Presence] in Serum

3.20

7.33

1.0

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

471

3381

1.31

7.33

5.3

5.0

350.40

353.92

umol/l

0.22

411

2912

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

330

2245

1.38

7.32

1.1

83.65

67.65

au/ml

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

133

2.68

7.30

1.4

1.2

52.93

43.42

mg/l

1.12

(3023410) Appearance of Cerebral spinal fluid

337

2307

1.37

7.21

1.6

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

826

6361

1.22

7.14

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

218

1382

1.48

7.13

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

160

949

1.58

7.10

1.6

1.4

—

(3024263) Appearance of Synovial fluid

211

1332

1.49

7.05

1.5

1.6

—

(3002079) Sodium [Moles/time] in 24 hour Urine

179

1094

1.54

6.98

1.3

1.2

161.57

162.98

mmol/24h

0.08

179

1094

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

231

1489

1.46

6.96

1.1

4.55

7.45

nmol/l

0.70

272

(3016750) Collection duration of Urine

233

1505

1.46

6.95

2.6

2.1

490.16

500.44

min

1.05

190

1073

(3008295) Osmolality of Serum or Plasma

413

2935

1.32

6.93

1.4

1.3

279.75

276.60

mosm/kgh2o

1.65

300

2238

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

239

1555

1.45

6.86

1.1

1.2

48.37

46.76

mg/l

0.14

221

1303

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

478

3474

1.30

6.82

1.6

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

142

827

1.61

6.82

1.3

1.2

—

(4281824) Cell count and differential, peritoneal fluid

389

2749

1.33

6.80

1.2

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

406

2888

1.32

6.78

1.1

2.64

2.86

0.18

385

(3018133) Calcium [Moles/volume] in Urine

383

1.91

6.76

1.4

1.5

2.50

2.81

mmol/l

0.62

347

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

425

1.86

6.66

1.1

1000.00

919.61

titre

0.25

102

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

366

1.92

6.63

1.3

1.2

1209.51

134.78

ng/l

0.46

250

(3009871) Measles virus Ab [Titer] in Serum

140

819

1.61

6.62

1.6

5131.03

3493.90

titre

1.43

141

(40762365) Oxygen content in Arterial blood by calculation

427

1.85

6.57

4.0

2.9

14.45

14.79

ml/dl

0.47

396

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

228

1485

1.44

6.54

1.1

327.95

303.84

mg/l

0.47

214

1306

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

435

1.84

6.51

2.0

1.9

6.33

141.82

pmol/l

0.59

115

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

676

5168

1.23

6.32

4.0

3.4

10.84

9.80

pmol/l

1.51

676

5162

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

152

918

1.56

6.30

1.1

2.44

6.36

u/ml

3.01

136

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

234

2.13

6.18

2.3

2.2

55.68

60.87

0.40

150

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

424

3079

1.30

6.14

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

431

1.81

6.09

1.3

1.2

8983.33

201424.00

u/ml

0.50

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

165

1023

1.52

6.09

1.1

1544.72

1564.18

miu/ml

0.08

165

1023

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

620

4717

1.24

6.08

1.4

136.77

184.02

pmol/l

2.22

605

4597

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

332

1.92

6.04

1.3

288895.62

213561.48

nmol/l

0.13

273

(3000060) B lymphocytes [#/volume] in Blood

508

1.74

6.04

2.1

1.9

2.10

1.03

e9/l

0.28

247

(3005532) Lymphocytes/Leukocytes in Pleural fluid

161

997

1.52

5.98

1.5

1.4

61.28

63.95

0.44

135

813

(4212803) Bone marrow aspirate examination

225

2.13

5.97

1.0

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

165

1029

1.51

5.93

1.9

2.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

103

574

1.69

5.93

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

155

955

1.53

5.90

1.7

2.1

173.54

165.41

0.51

142

893

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

342

1.89

5.88

1.0

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

128

756

1.59

5.87

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

691

5342

1.22

5.83

1.4

21.50

34.21

e6/l

1.09

520

3979

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

247

1675

1.39

5.71

2.1

1.9

16.54

16.16

0.20

241

1624

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

123

725

1.59

5.70

1.3

113.09

134.77

nmol/l

1.03

513

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

118

692

1.60

5.60

1.2

13.42

11.66

pmol/l

0.42

253

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

109

627

1.63

5.59

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

506

1.71

5.59

1.2

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

382

1.82

5.58

1.3

1.2

—

(40765096) Chromosome analysis panel by Banding

133

803

1.56

5.58

1.1

1.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

695

5408

1.21

5.52

1.5

1.4

4793.54

1673.21

e6/l

0.47

547

4313

(3023511) Choriogonadotropin [Units/volume] in Urine

171

1094

1.47

5.46

1.3

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

184

2.19

5.46

2.2

19.90

17.31

0.15

(3028707) Methadone [Presence] in Urine by Screen method

262

1813

1.36

5.37

2.1

2.6

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

127

2.44

5.33

5.7

4.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

203

1349

1.41

5.31

1.2

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

321

1.87

5.30

1.5

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

112

659

1.60

5.27

1.1

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

187

2.16

5.27

1.2

1.3

1.13

1.01

ml/s/173m2

0.27

114

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

152

958

1.49

5.25

1.7

2.5

163.49

263.60

ug/l

0.23

146

912

(1175426) CD3 cells/Lymphocytes in Blood

255

1764

1.36

5.25

2.1

2.0

71.50

72.01

0.20

244

1684

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

106

616

1.62

5.25

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

215

1448

1.40

5.22

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

194

2.13

5.21

1.3

1.4

—

(3000012) Reticulocyte production index

560

4291

1.23

5.21

2.2

0.95

0.90

436

2954

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

160

1022

1.47

5.18

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

160

1023

1.47

5.16

1.9

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

170

1100

1.45

5.15

1.6

1.7

82.26

109.41

umol/l

1.33

559

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

413

1.75

5.14

1.2

72.81

74.15

0.07

130

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

272

1.93

5.12

1.2

78.74

105.90

ug/l

0.95

166

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

169

1095

1.45

5.09

1.2

1.1

1.28

1.13

u/l

0.37

488

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

110

652

1.58

5.04

1.9

1.6

9.27

9.42

ug/l

0.14

110

652

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

200

1343

1.40

4.96

1.2

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1261

13423

0.88

4.95

1.8

3.41

3.46

mmol/l

0.69

876

9612

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

285

2025

1.32

4.94

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

344

1.80

4.88

2.4

1.9

—

(3035880) pH of Pleural fluid

232

1604

1.36

4.83

1.4

1.3

7.41

7.40

0.16

167

1133

(3012494) Peanut IgE Ab [Units/volume] in Serum

401

1.73

4.80

1.1

1.0

0.66

0.79

u/ml

0.16

201

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

415

1.72

4.80

1.2

78.96

84.57

0.44

137

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

284

2026

1.32

4.80

1.3

1.2

—

(3026480) Teichoate Ab [Titer] in Serum

233

1.97

4.78

1.2

1.0

—

2.00

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

123

759

1.52

4.75

1.2

1.3

3.04

3.41

umol/l

0.62

109

660

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

341

1.79

4.71

1.0

1.1

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

233

1623

1.35

4.64

1.8

1.7

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

249

1.92

4.63

1.0

—

(21494815) CD4 cells/Lymphocytes in Specimen

282

2021

1.31

4.63

2.1

39.75

37.76

1.24

272

1982

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

316

1.81

4.62

1.2

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

182

1219

1.40

4.62

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

103

615

1.57

4.61

2.0

1.9

9.00

8.93

mg/l

0.04

510

(3033923) Metanephrine [Moles/time] in 24 hour Urine

502

1.63

4.50

1.1

0.73

0.79

umol/24h

0.17

239

(3006576) Bicarbonate [Moles/volume] in Blood

141

906

1.46

4.49

6.9

6.3

25.03

25.08

mmol/l

0.05

127

820

(3025130) Human papilloma virus identified in Specimen

333

2453

1.28

4.45

1.7

1.8

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

294

1.82

4.39

1.6

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

282

2038

1.30

4.38

1.4

0.31

0.29

nmol/l

0.22

203

1418

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

146

2.19

4.35

1.0

1.1

1.96

1.55

iu/ml

0.75

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

309

1.79

4.34

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

341

2529

1.27

4.32

1.5

—

(3017569) Oxygen content in Arterial blood

233

1643

1.33

4.31

2.4

2.2

15.59

15.82

0.49

233

1643

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

266

1914

1.31

4.27

1.2

1.3

2.09

2.24

mmol/l

1.30

245

1778

(4027681) Cerebrospinal fluid IgG ratio and IgG index

165

1105

1.40

4.23

1.1

1.3

0.54

0.64

ratio

0.93

112

631

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

396

1.68

4.20

1.6

1.4

74.24

73.04

0.31

383

(3011288) Drugs identified in Urine by Screen method Nominal

362

2715

1.25

4.19

2.3

2.9

—

(3008536) Aspergillus sp Ab [Presence] in Serum

549

1.57

4.17

1.9

2.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

155

2.12

4.17

1.0

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

193

1.99

4.16

1.1

1.2

0.46

0.20

nmol/l

0.92

128

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

102

624

1.54

4.15

1.3

1.2

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

120

762

1.48

4.10

1.3

1.4

57.40

57.37

0.00

100

654

(3023436) Glucagon [Mass/volume] in Serum or Plasma

138

2.18

4.07

1.9

1.8

242.96

202.70

ng/l

0.45

125

(44786800) Granulocytes/Leukocytes in Body fluid

337

1.73

4.04

1.3

20.24

25.20

0.71

258

(3002619) Bacteria identified in Specimen by Culture

108

674

1.50

4.02

1.2

1.3

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

170

2.04

4.02

1.5

1.4

14.11

16.02

pmol/l

0.39

148

(3027231) Wheat IgE Ab [Units/volume] in Serum

290

1.78

3.98

1.1

1.0

1.50

1.80

u/ml

0.09

241

(3042631) Mycobacterium sp identified in Specimen

504

3938

1.20

3.96

2.9

2.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

225

1601

1.32

3.95

2.2

1.9

8.23

8.13

mmol/l

0.12

225

1601

(3028679) Herpes simplex virus Ab [Presence] in Serum

152

1018

1.40

3.93

1.2

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

103

641

1.51

3.90

1.7

1.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

204

1435

1.34

3.89

1.1

11.12

9.12

iu/ml

0.44

333

(3009015) Lactate [Moles/volume] in Synovial fluid

300

1.75

3.86

1.3

6.25

6.85

mmol/l

0.21

143

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

185

1284

1.35

3.86

1.6

1.5

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

392

1.65

3.85

1.6

1.4

1979.56

710.63

mu/l

0.40

379

(3010726) Horse dander IgE Ab [Units/volume] in Serum

331

2488

1.25

3.80

1.1

1.04

1.01

u/ml

0.03

178

1208

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

177

1224

1.36

3.78

4.0

3.4

1.23

1.32

0.29

177

1224

(3024666) Lithium [Moles/volume] in Serum or Plasma

148

994

1.40

3.78

13.2

13.5

0.63

0.64

mmol/l

0.29

138

912

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

261

1.80

3.76

1.2

0.13

0.36

u/ml

—

(3028717) Thiamine [Mass/volume] in Blood

310

1.73

3.74

1.2

1.1

65.12

63.35

ug/l

0.23

310

(3010503) CD19 cells [#/volume] in Blood

213

1518

1.32

3.73

2.5

144.23

361.49

e6/l

1.81

205

1467

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.80

3.65

1.4

1.2

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

191

1.92

3.59

1.7

1.6

1.33

1.41

umol/l

0.53

127

(1616796) Gas panel - Central venous blood

778

6359

1.15

3.58

4.4

3.8

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

503

1.55

3.58

1.2

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

322

1.69

3.55

2.4

2.8

81.82

75.89

pmol/l

0.17

283

(3010370) Gastrin [Moles/volume] in Serum or Plasma

387

1.63

3.54

1.6

1.9

64.75

54.58

pmol/l

0.30

327

(3005011) Chlamydia sp Ab [Titer] in Serum

260

1.77

3.52

1.9

1.6

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

180

1.93

3.48

1.2

24.33

23.81

—

(21491868) Cryoglobulin [Mass/volume] in Serum

131

876

1.40

3.47

1.3

1.2

0.23

0.60

g/l

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

332

1.67

3.45

1.2

1.3

56.88

49.78

0.50

150

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

111

2.20

3.44

2.0

1.9

1.56

2.11

mg/l

1.18

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

191

1358

1.32

3.43

1.9

3.05

2.97

u/field

0.03

128

948

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

228

1.81

3.42

1.2

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1855

18911

0.91

3.40

2.1

3.50

3.46

ratio

0.52

1476

15189

(3032352) Blasts [#/volume] in Cerebral spinal fluid

271

1.73

3.36

1.6

1.8

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

401

3121

1.21

3.36

1.8

2.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

131

883

1.39

3.33

1.3

292.10

238.84

ug/l

0.11

476

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

285

2143

1.25

3.32

2.0

2.36

2.90

u/field

0.19

157

1168

(3028626) Oxygen [Partial pressure] in Capillary blood

836

6909

1.14

3.31

3.3

3.1

8.00

7.98

kpa

0.09

818

6739

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.32

3.29

1.4

141.60

120.75

ug/l

0.15

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

613

1.47

3.28

1.1

1.2

76.27

86.35

1.41

312

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

324

1.65

3.23

2.2

2.0

16.45

17.66

umol/l

0.50

324

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

382

1.60

3.23

3.5

2.5

70.04

55.99

mg/l

0.21

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.35

3.23

3.1

4.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

150

1042

1.35

3.19

1.1

408.71

548.69

ng/l

0.25

299

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

115

2.12

3.17

1.0

1.2

0.44

0.57

iu/ml

0.25

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

193

1.85

3.17

1.2

1.0

0.16

0.59

u/ml

0.42

127

(3016879) Cocaine [Presence] in Urine

475

3776

1.18

3.17

1.8

2.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

626

1.45

3.15

1.1

78.34

86.35

1.67

316

(3023430) Cat dander IgE Ab [Units/volume] in Serum

278

2100

1.24

3.13

1.1

2.96

3.12

u/ml

0.07

121

880

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

242

1.75

3.13

1.0

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

133

913

1.37

3.06

1.1

1.0

2.01

1.16

u/ml

0.39

287

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

182

1.86

3.06

1.2

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

328

2529

1.22

3.06

1.6

1.5

25.64

29.32

1.29

226

1524

(3000919) Neutrophils/Leukocytes in Pleural fluid

117

787

1.40

3.05

1.5

1.4

23.87

20.26

0.68

104

709

(3025018) Bordetella pertussis Ab [Titer] in Serum

184

1327

1.30

3.04

1.3

1.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.38

3.02

1.1

1.0

—

(3004451) EKG impression Narrative

230

1709

1.26

3.01

1.3

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.49

2.98

1.4

1.2

27.58

54.21

umol/24h

0.59

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

106

704

1.41

2.98

1.1

—

(3021901) Oxygen saturation in Capillary blood

740

6116

1.14

2.97

3.5

3.0

89.61

89.59

0.04

721

5946

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

466

1.51

2.96

2.1

2.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

240

1.72

2.93

1.0

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

190

1387

1.29

2.88

6.4

7.0

15.52

109.90

ug/l

2.30

121

877

(3001893) Eosinophils/Leukocytes in Pleural fluid

126

867

1.36

2.88

1.5

1.4

2.25

2.77

0.33

102

730

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

137

960

1.34

2.80

2.4

2.3

55.31

52.92

umol/l

0.32

108

811

(3034426) Prothrombin time (PT)

643

1.42

2.78

1.3

1.2

28.20

28.23

0.02

643

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

148

1.90

2.77

1.1

39.30

99.22

u/l

0.74

115

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

135

1.95

2.76

4.2

3.5

—

(3024869) Neuronal Ab [Presence] in Serum

505

1.47

2.74

1.1

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

432

1.50

2.66

1.5

1.4

13.82

11.01

0.43

213

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.23

2.65

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

144

1.89

2.64

1.1

1.0

0.67

0.55

u/ml

0.09

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

158

1.84

2.61

1.2

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

138

1.90

2.61

1.2

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

3.67

2.59

1.4

1.1

1.56

1.39

—

(3028300) Cannabinoids [Presence] in Urine

500

4069

1.16

2.56

1.8

2.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

316

1.57

2.56

2.8

2.7

0.62

0.53

u/field

0.30

316

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

104

710

1.38

2.54

9.4

7.9

5.88

5.98

kpa

0.68

626

(3014599) Egg white IgE Ab [Units/volume] in Serum

125

879

1.34

2.53

1.0

2.59

0.89

u/ml

0.65

196

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

3.04

2.52

7.5

7.9

8438.91

544.64

e6/l

0.43

(3027008) Opiates [Presence] in Urine

498

4059

1.15

2.51

1.8

1.9

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

322

2535

1.19

2.49

1.2

7.63

7.62

mmol/l

0.02

266

2184

(3014133) Dog dander IgE Ab [Units/volume] in Serum

286

2228

1.21

2.48

1.1

2.03

2.97

u/ml

0.90

131

1066

(40762814) Titanium [Mass/volume] in Blood

486

1.45

2.47

2.5

2.82

3.62

ug/l

1.99

180

(3013945) Hepatitis B virus e Ab [Presence] in Serum

121

1.94

2.47

1.8

1.4

—

(3027944) Amphetamines [Presence] in Urine

488

3980

1.15

2.45

1.7

1.9

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

2.19

2.43

1.0

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

440

3565

1.16

2.42

1.6

1.5

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

677

1.37

2.42

1.4

1.3

37.16

37.73

0.05

455

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

321

1.55

2.41

1.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

118

830

1.33

2.41

1.3

1.2

12.74

11.60

mm/h

0.37

118

830

(3033093) Yersinia sp IgM Ab [Titer] in Serum

3.38

2.40

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

3.38

2.40

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

3.38

2.40

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

3.38

2.40

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

3.38

2.40

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

3.38

2.40

2.0

—

(3025577) Chromium [Mass/volume] in Blood

222

1694

1.23

2.38

2.2

2.27

2.32

ug/l

0.08

183

1408

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

240

1847

1.22

2.37

1.2

10.25

9.43

mmol/l

1.67

221

1719

(40757373) Influenza virus identified in Isolate

475

1.44

2.37

1.8

1.6

—

(3027874) Urate [Moles/volume] in Urine

2.03

2.36

1.1

1.75

1.81

mmol/l

0.07

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

164

1.77

2.35

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

221

1.66

2.33

1.1

1.0

—

(3000764) Benzodiazepines [Presence] in Urine

492

4033

1.15

2.32

1.8

1.9

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

589

1.39

2.28

1.3

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

209

1.66

2.25

1.1

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

615

1.37

2.23

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

497

1.42

2.23

1.5

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

258

2016

1.20

2.21

1.0

296.22

349.99

ng/l

1.52

184

1438

(3038071) Oxygen [Partial pressure] in Mixed venous blood

625

1.37

2.20

9.6

7.8

6.16

5.54

kpa

1.10

625

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

225

1.63

2.19

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

258

2021

1.20

2.16

1.0

726.31

739.26

ng/l

0.16

182

1391

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

160

1193

1.26

2.15

1.1

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

101

1.95

2.14

1.4

1.6

280.80

543.59

nmol/l

2.96

101

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

286

1.54

2.13

1.3

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

637

1.36

2.12

1.2

107.56

106.15

0.10

581

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

258

2026

1.20

2.11

1.0

41.43

42.22

ng/l

0.09

180

1427

(3019768) Coxiella burnetii Ab [Presence] in Serum

142

1.78

2.11

1.4

1.1

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

115

1.88

2.10

1.7

1.5

4.58

3.39

mg/l

0.34

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

115

1.88

2.10

1.7

1.5

0.71

2.06

mg/l

1.85

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

115

1.88

2.10

1.7

1.5

2.77

2.48

mg/l

0.11

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

115

1.88

2.10

1.7

1.5

3.31

0.70

mg/l

0.92

(3023323) Follitropin [Units/volume] in Serum or Plasma

752

6370

1.11

2.10

1.4

30.39

33.98

iu/l

2.14

631

5466

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

129

1.82

2.08

1.2

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

237

1.58

2.04

1.0

0.54

0.40

u/ml

0.09

152

(4198724) Urine methamphetamine measurement

522

1.38

2.04

1.6

1.9

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

335

1.48

2.03

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

201

1.63

2.03

1.1

1.0

—

(3033086) Enterovirus Ab [Titer] in Serum

2.11

2.01

1.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

352

1.47

1.99

7.1

5.2

51.77

48.50

ug/min

0.17

285

(3003740) Influenza virus B Ag [Presence] in Specimen

357

2897

1.16

1.99

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

396

3238

1.15

1.99

5.6

8.7

7.47

7.46

mmol/l

0.03

314

2696

(3017461) Flecainide [Moles/volume] in Serum or Plasma

152

1.73

1.99

1.2

1.6

0.84

0.75

umol/l

0.25

114

(3026470) Cobalt [Mass/volume] in Blood

225

1757

1.20

1.98

2.3

2.2

4.39

3.66

ug/l

0.60

206

1627

(3050794) Legionella sp Ab [Presence] in Serum

239

1.57

1.98

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

515

5427

0.89

1.94

4.5

3.5

27.62

27.80

mg/l

0.04

357

3822

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

124

912

1.28

1.90

3.2

2.8

10.14

10.28

kpa

0.17

124

912

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

124

912

1.28

1.90

3.2

2.8

4.84

4.97

kpa

0.67

124

912

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

183

1.64

1.90

1.1

8.88

10.33

u/l

0.20

183

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

372

1.44

1.89

1.2

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

155

1.70

1.87

1.3

1.1

13.08

18.39

nmol/l

—

(3002523) Influenza virus A Ag [Presence] in Specimen

355

2896

1.15

1.87

1.1

—

(3042301) Urate [Moles/volume] in Synovial fluid

2.22

1.84

1.0

264.43

379.34

umol/l

—

(3014891) Appearance of Pleural fluid

382

1.42

1.84

1.6

1.5

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

3.13

1.83

1.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

237

1876

1.19

1.83

1.1

1.0

0.19

0.34

u/ml

0.58

628

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.90

1.82

1.2

1.3

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

1.90

1.82

1.1

1.0

0.10

0.06

u/ml

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

186

1442

1.21

1.80

1.8

1.7

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

417

1.40

1.76

1.5

1.2

655.98

133.43

u/l

0.44

294

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

155

1184

1.23

1.75

1.1

1.07

ratio

0.16

132

965

(3042010) Triglyceride [Moles/volume] in Pleural fluid

475

1.36

1.71

1.4

1.2

1.18

1.30

mmol/l

0.05

304

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

256

1.50

1.71

1.1

1.0

97.64

84.15

ug/l

0.64

184

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

185

1442

1.20

1.71

1.8

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

185

1442

1.20

1.71

1.8

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

185

1442

1.20

1.71

1.8

1.7

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2232

22007

0.95

1.71

4.9

4.1

1.22

1.23

mmol/l

1.41

2013

18884

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

476

1.36

1.70

1.7

1.6

48.26

97.85

au/ml

1.25

(3019174) dRVVT (LA screen)

160

1.64

1.69

1.0

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

334

1.43

1.69

1.4

1.7

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

104

1.80

1.67

1.1

1.0

0.26

0.13

u/ml

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

118

1.75

1.66

1.4

1.6

0.36

0.16

u/l

0.34

(3000285) Sodium [Moles/volume] in Blood

559

1.33

1.65

1.3

138.66

138.23

mmol/l

0.43

474

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1057

0.77

1.65

1.5

1.4

1.18

1.15

ratio

0.09

631

(3006567) Chloride [Moles/time] in 24 hour Urine

2.35

1.59

1.2

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

2.50

1.58

1.1

1.0

1712.50

1893.33

titre

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

308

1.43

1.57

1.1

15.22

20.96

u/l

1.88

198

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

108

804

1.26

1.56

1.4

1.8

8.16

5.26

ug/l

0.23

553

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

340

1.41

1.56

1.6

1.3

64.66

73.47

1.22

288

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1058

0.78

1.55

1.5

1.4

1.28

1.18

ratio

0.45

635

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1058

0.78

1.55

1.5

1.4

0.95

ratio

0.03

632

(3027974) Hepatitis B virus e Ag [Presence] in Serum

128

1.69

1.55

1.9

1.5

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

690

1.28

1.53

2.0

1.6

—

198.43

iu/ml

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

165

1.59

1.53

6.6

4.9

—

(3032868) Hemoglobin electrophoresis panel in Blood

165

1.59

1.53

1.7

1.5

—

(3012898) Urea [Moles/volume] in Urine

264

1.46

1.51

1.3

139.21

164.16

mmol/l

0.88

227

(3022475) Manganese [Moles/volume] in Blood

122

1.69

1.51

1.3

1.2

0.14

0.16

umol/l

0.67

122

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

2.81

1.47

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

473

1.33

1.46

1.3

1.2

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

138

1.63

1.45

1.2

1.3

0.07

g/l

0.32

104

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

713

1.26

1.44

1.9

2.0

45.96

41.11

u/l

0.09

653

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1046

0.79

1.44

1.4

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.28

1.41

3.2

2.4

1.60

3.10

mu/l

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1136

0.80

1.40

1.6

1.5

64.04

60.08

ug/l

0.30

918

(3017509) Phencyclidine [Presence] in Urine

125

1.65

1.40

1.5

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

894

0.78

1.39

1.5

1.4

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

118

1.67

1.39

1.0

10.97

0.67

u/ml

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

246

1.45

1.38

1.9

2.0

0.76

0.96

mmol/l

0.44

151

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

129

996

1.22

1.38

20.3

17.8

1305.55

2385.82

nmol/l

0.58

121

952

(3022229) Phosphate [Moles/volume] in Urine

1.81

1.37

1.1

13.01

16.12

mmol/l

0.56

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

116

887

1.23

1.37

2.9

3.1

29.46

28.36

umol/l

0.51

676

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.94

1.36

7.2

10.2

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

156

1.56

1.34

1.2

1.4

—

18935.17

—

(3007700) Barley IgE Ab [Units/volume] in Serum

1.88

1.34

1.1

1.0

0.10

0.36

u/ml

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.16

1.34

1.6

1.2

200.56

251.36

u/ml

—

(3019298) Eosinophils/Leukocytes in Peritoneal fluid

1.98

1.32

2.3

1.2

0.54

0.44

0.17

(3010421) pH of Blood

1000

8791

1.07

1.30

4.6

3.7

7.41

5.28

982

8666

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.35

1.28

1.1

1.3

1.53

2.01

g/l

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

107

1.67

1.26

1.1

1.0

8.57

8.64

mmol/l

0.06

107

(3013762) Body weight Measured

2.08

1.26

1.0

1.3

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

122

1.61

1.25

1.0

0.02

u/ml

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

487

1.29

1.23

2.7

538.72

1807.09

u/l

2.00

432

(3022806) Fractional oxyhemoglobin in Capillary blood

319

3342

0.89

1.21

1.9

1.8

88.59

89.41

1.43

313

3293

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.76

1.20

1.0

0.17

0.10

u/ml

0.17

(3044009) aPTT.lupus sensitive (LA screen)

161

1.52

1.20

1.0

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

106

1204

0.83

1.19

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

186

1508

1.16

1.18

1.4

1.3

158.01

170.61

pmol/l

0.66

186

1508

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

124

1.59

1.18

1.0

0.02

0.15

u/ml

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

923

0.80

1.17

1.5

—

(3005033) Fetal Nuchal fold Thickness US

881

0.80

1.17

1.5

1.4

1.22

1.27

0.50

604

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

1.88

1.17

1.4

1.6

148.29

221.39

nmol/l

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

1.91

1.13

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.91

1.13

1.0

1.1

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

250

1.39

1.12

1.2

—

1.00

mmol/l

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

219

1.41

1.10

1.3

1.5

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

183

0.56

1.10

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

204

1.43

1.09

2.1

1.8

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.88

1.08

1.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

785

6902

1.07

1.7

4.62

4.61

mg/l

0.01

632

5220

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

470

0.74

1.06

1.2

—

(3051339) Copper [Moles/volume] in Blood

113

1.58

1.06

2.2

1.2

18.04

16.25

umol/l

1.31

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

516

1.25

1.05

1.2

111.43

40.03

mg/l

0.41

370

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.61

1.03

1.2

1.1

230.38

289.31

nmol/l

1.21

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

494

1.25

1.01

6.9

6.6

10.69

10.49

0.30

494

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

682

1.21

0.99

1.2

1.1

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.76

0.98

1.0

—

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

1.81

0.98

8.6

9.8

39.67

50.48

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.98

0.0

1.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

118

941

1.18

0.97

16.4

13.3

770.69

2209.93

nmol/l

0.53

111

903

(3011335) Digoxin [Mass/volume] in Serum or Plasma

243

0.66

0.95

1.8

2.4

0.62

0.67

ug/l

0.26

243

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.69

0.95

1.0

3.88

2.44

u/ml

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

109

1.55

0.95

1.1

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

283

1.33

0.94

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

180

1914

0.88

0.94

1.5

982.59

1012.31

mu/l

0.16

136

1537

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.16

0.92

1.2

1.0

2684.83

3467.35

titre

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

443

1.25

0.90

1.3

1.8

1.72

2.51

ug/l

2.22

267

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

385

1.27

0.90

2.6

3.4

55.24

124.83

ng/l

2.22

130

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

571

0.79

0.89

1.4

1.3

1.18

mmol/l

0.19

571

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.80

0.89

1.1

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

278

1.32

0.89

1.1

1.0

—

(3018001) Oat IgE Ab [Units/volume] in Serum

111

1.52

0.89

1.2

1.0

0.52

0.25

u/ml

0.38

(40768793) Breast Pathology biopsy report

637

5608

1.07

0.88

1.3

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

479

1.23

0.87

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

190

1.38

0.87

1.1

1.0

0.03

0.05

u/ml

0.78

190

(46235168) Fasting glucose [Moles/volume] in Blood

259

0.69

0.86

2.0

2.4

6.78

7.49

mmol/l

0.98

121

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

567

1.21

0.84

1.8

—

(3016228) CD19 cells/cells in Blood

122

992

1.15

0.83

2.1

2.0

7.76

8.06

0.10

117

965

(3033942) Copper [Moles/time] in 24 hour Urine

1.58

0.82

1.1

0.21

0.72

umol/24h

—

(3045462) Protein/Creatinine [Ratio] in Urine

185

1.37

0.80

1.7

3.2

45.80

38.10

mg/mmol

0.17

169

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.79

0.0

1.0

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

597

1.19

0.79

1.5

1.2

1.47

1.58

mmol/l

0.43

371

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

157

1659

0.89

0.79

1.5

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

197

0.67

0.76

1.4

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

163

1.38

0.76

1.0

1.2

—

(40768800) Prostate Pathology biopsy report

709

6302

1.06

0.75

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

145

1204

1.13

0.75

5.7

5.5

67.67

4464.19

u/ml

0.68

184

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

188

1.35

0.74

1.2

1.1

96.00

97.70

titre

0.06

188

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.62

0.73

1.0

1.1

3.89

2.40

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

134

1113

1.13

0.70

1.2

66.17

59.95

0.25

123

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

182

1.34

0.70

1.0

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.53

0.68

1.1

1.0

—

(3027035) Albumin [Mass/time] in 24 hour Urine

241

1.28

0.68

1.3

1.4

263.20

341.43

mg/24h

—

(4038314) Semen analysis, post vasectomy

1.64

0.67

1.1

1.3

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

176

1.33

0.66

1.3

1.4

26.18

42.32

1.34

112

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.47

0.66

1.2

1.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

168

1.34

0.66

2.8

2.4

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.60

0.65

1.1

1.4

2.53

2.02

mmol/24h

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

120

1.41

0.65

1.1

1.0

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

1.62

0.65

1.0

0.50

0.14

u/ml

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

185

1.32

0.64

3.2

3.0

9.95

60.38

pmol/l

1.41

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

154

1.34

0.61

1.3

1.5

16.25

12.96

0.22

103

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.56

0.60

2.5

5.2

—

(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.59

0.0

1.2

—

468.00

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

147

1.34

0.59

1.0

1.2

2706.43

3785.66

ng/l

0.21

(3009992) Blasts/cells in Bone marrow

0.00

0.58

0.0

1.5

—

17.59

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.58

0.0

1.0

—

1.19

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.47

0.56

1.1

1.2

26.26

34.83

mg/24h

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.66

0.56

1.0

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

224

1.26

0.55

6.2

5.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

588

1.15

0.53

1.3

1.4

0.09

0.29

mmol/l

—

127

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

466

1.17

0.53

1.7

1.8

1.20

1.19

mmol/l

0.52

451

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

226

1968

1.08

0.52

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

226

1.25

0.52

3.0

2.6

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

243

1.24

0.51

1.1

2.12

1.74

umol/24h

1.62

243

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2980

27431

1.02

0.51

3.9

3.6

—

(3002719) Hemoglobin [Mass/volume] in Urine

1.48

0.51

1.0

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

135

1.32

0.50

1.4

1.2

—

(3024316) Viscosity of Plasma

127

1.33

0.49

2.8

2.0

1.69

1.76

mpas

0.21

(3018291) Platelet Ab [Presence] in Serum

1.56

0.49

1.0

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

1.42

0.48

1.0

8.00

1.98

u/ml

0.33

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

251

0.78

0.48

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

178

1802

0.93

0.46

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

230

1.22

0.46

1.1

11.82

20.09

iu/ml

0.66

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.43

0.46

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.43

0.46

1.0

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

169

1713

0.92

0.45

1.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

207

0.77

0.45

1.1

1.0

9.24

12.04

u/ml

0.22

207

(3020123) Porphyrins [Interpretation] in Serum or Plasma

113

1.33

0.44

1.2

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

483

1.15

0.44

1.5

1.4

237.50

368.32

titre

—

(3003577) Lead [Moles/volume] in Blood

155

1.27

0.44

1.1

1.4

0.12

0.13

umol/l

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

360

0.83

0.44

1.5

1.6

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.62

0.43

1.0

0.40

0.04

u/ml

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

198

1.23

0.43

1.1

6.17

6.31

mmol/l

0.42

198

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

105

894

1.10

0.43

1.1

22.00

9.68

u/ml

—

(3010937) Rubella virus Ab [Presence] in Serum

0.65

0.42

1.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

233

1.21

0.42

1.0

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

216

1.22

0.41

1.6

1.4

—

14.17

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

311

1.18

0.41

1.4

1.2

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

60.00

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.41

0.0

1.1

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.41

0.0

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

115

1.31

0.40

1.0

0.01

0.14

u/ml

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

312

1.17

0.40

1.4

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

312

1.17

0.40

1.4

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.68

0.39

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.67

0.39

1.0

0.08

—

(40768795) Lymph node Pathology biopsy report

299

2664

1.05

0.38

1.2

—

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

133

1.27

0.38

1.2

1.4

1.08

1.83

0.29

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.36

0.38

1.1

1.0

—

(4034850) Laboratory test

855

7789

1.03

0.37

14.8

10.9

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.30

0.37

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.28

0.36

1.2

1.1

0.02

0.04

u/ml

—

(3042517) Benzodiazepines panel - Urine

126

1.27

0.36

1.1

2.8

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.36

0.36

1.1

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

1.44

0.35

1.0

1.4

20.50

41.52

e6/l

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

824

1.09

0.35

1.1

99.82

97.35

0.32

643

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

118

1.27

0.35

1.2

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

152

1.23

0.35

1.1

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

335

1.15

0.34

1.1

51.88

32.66

iu/ml

0.77

335

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.32

0.34

1.1

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

167

0.79

0.34

1.0

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

153

1.23

0.33

1.7

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

310

1.15

0.33

6.4

7.9

0.35

0.41

umol/l

0.26

275

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

479

1.12

0.32

1.6

1.5

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.28

0.32

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

186

0.81

0.32

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

447

4053

1.03

0.29

3.2

3.8

34.83

41.46

u/ml

0.30

435

3928

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

287

1.14

0.29

2.7

3.1

1.19

1.22

mg/l

0.07

220

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

105

1.25

0.28

24.1

13.0

103.64

105.88

g/l

0.34

105

(40761539) Cells [Type] in Urine sediment by Light microscopy

657

0.91

0.28

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

658

6015

1.03

0.27

3.1

2.7

15.79

16.29

4.17

643

5885

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

486

1.10

0.27

1.1

1.0

3.82

8.18

u/ml

1.59

295

(3015076) Soybean IgE Ab [Units/volume] in Serum

784

1.08

0.27

1.1

1.0

0.71

0.65

u/ml

0.04

193

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

115

1.22

0.25

1.1

1.4

0.80

1.17

u/field

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

770

0.93

0.25

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

770

0.93

0.25

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

770

0.93

0.25

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

770

0.93

0.25

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

714

1.08

0.25

3.0

2.5

142.49

147.92

nmol/l

0.13

624

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

562

0.92

0.23

2.5

2.4

7.91

7.40

mmol/l

0.38

347

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

591

0.92

0.23

2.2

1.6

0.75

1.50

u/ml

0.95

144

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.20

0.21

2.2

1.9

230.28

240.94

ug/l

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.87

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.21

0.0

1.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.3

—

(3027315) Oxygen [Partial pressure] in Blood

639

5869

1.02

0.20

5.4

4.0

8.34

8.51

kpa

1.39

619

5732

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.20

0.0

1.0

—

180.62

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

233

2262

0.97

0.19

1.4

1.5

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.20

0.19

1.2

1.3

—

176837.50

—

(3050129) First trimester maternal screen panel - Serum or Plasma

142

1274

1.05

0.19

1.5

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

104

928

1.05

0.18

1.4

1.5

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

765

1.05

0.17

1.2

1.3

16.57

25.89

0.59

117

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

133

1197

1.04

0.16

1.2

1.1

18.07

21.54

u/ml

0.36

420

(44806420) Estimation of glomerular filtration rate

241

2328

0.97

0.16

2.8

2.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

872

8061

1.02

0.16

1.7

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.18

0.16

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

203

1845

1.03

0.16

1.5

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.10

0.16

1.3

1.1

—

mmol/l

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

161

0.87

0.15

2.9

3.1

43.60

43.86

0.02

161

(40763480) Human metapneumovirus Ag [Presence] in Specimen

114

1.15

0.14

1.4

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

160

0.88

0.14

5.7

6.2

9.60

8.39

0.26

160

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.82

0.13

1.0

1.2

1.28

1.34

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

153

1481

0.97

0.13

4.2

3.8

—

(40758358) Immune stain study

106

1.15

0.13

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

488

1.06

0.12

4.8

6.0

8.93

8.46

mmol/l

0.23

488

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

851

0.96

0.12

1.7

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

179

1.10

0.11

1.2

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

667

6332

0.99

0.11

1.5

1.4

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

331

0.94

0.11

1.8

3.3

39.29

40.17

umol/l

0.09

275

(3001729) Color of Synovial fluid

208

1.08

0.10

1.4

1.6

—

(3001556) Androgen free Index in Serum or Plasma

1.08

0.08

2.1

1.3

—

(3009677) Dengue virus Ab [Presence] in Serum

0.82

0.07

1.0

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.06

0.07

1.0

1.1

0.01

1.04

u/ml

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.06

0.07

1.3

1.0

0.88

1.19

u/ml

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.13

0.07

1.4

1.1

0.08

0.05

mg/l

—

(3013290) Carbon dioxide [Partial pressure] in Blood

628

5841

1.01

0.07

5.4

4.0

5.04

4.99

kpa

0.74

608

5705

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.03

0.07

1.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

129

1.09

0.07

1.5

1.6

23.06

23.90

mmol/l

—

(3020650) Glucose [Presence] in Urine

799

0.97

0.06

1.6

1.7

0.05

estimate

0.02

799

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.88

0.06

1.0

1.1

—

(3035082) Kappa light chains [Mass/volume] in Urine

1.11

0.06

1.1

0.04

0.13

g/l

—

(3012501) Base excess in Blood by calculation

627

5840

1.01

0.05

5.4

4.0

2.72

2.58

mmol/l

0.59

445

4046

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

121

1.09

0.05

10.5

8.7

—

(3041806) Other cells [#/volume] in Blood by Manual count

141

1.06

0.04

1.9

1.5

0.56

0.49

e9/l

0.43

141

(3034891) Synovial lining cells/cells in Synovial fluid

146

1353

1.01

0.03

1.5

4.38

4.02

0.11

269

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

653

1.02

0.03

1.4

1.5

53.13

59.85

ug/l

0.59

653

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

310

0.97

0.03

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

149

0.94

0.03

1.3

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

451

4251

1.00

0.03

1.7

—

20.58

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

189

1.04

0.02

1.5

2.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

190

1.04

0.01

2.5

2.6

—

(3012565) Volume of 24 hour Urine

141

1331

0.99

0.01

2.3

2.2

1888.77

1935.65

0.18

131

1170

(4133840) Spirometry

579

0.99

0.01

1.2

—

(40758292) HTLV I+II Ab panel - Serum

453

1.01

0.01

1.5

1.3

—

(40763590) HLA-DQ beta [Type]

1.07

0.01

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

541

0.99

0.01

1.1

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

381

0.98

0.00

1.1

1.2

—

(44806071) Cardiolipin IgM antibody measurement

288

1.01

0.00

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.01

0.00

1.0

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

139

1.01

0.00

1.4

304.53

334.73

umol/24h

0.21

139

(3028271) Lactate [Moles/volume] in Capillary blood

470

4410

1.00

0.00

2.0

1.9

1.73

mmol/l

0.02

456

4285

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

394

1.00

0.00

1.2

77.29

68.74

u/ml

0.27

382

(3013862) HLA-DP [Type]

1.03

0.00

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.98

0.00

1.6

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

841

1.00

0.00

2.0

2.06

1.79

ratio

0.63

813

(40760410) HLA-B [Type] by High resolution

1.04

0.00

1.0

—

(40760409) HLA-A [Type] by High resolution

1.04

0.00

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.04

0.00

1.0

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

0.0

1.1

—

33.78

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3006598) pH of Arterial cord blood

0.00

-0.00

0.0

1.2

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3016072) Theophylline [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

7.62

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.98

-0.00

1.0

1.1

2.29

1.31

u/field

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

-0.00

0.0

1.6

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.0

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

0.88

-0.00

1.0

1.4

—

1662.11

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

4.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_COLON and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_COLON	1.273 [1.17, 1.38]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.017

During the follow-up period (1.1.1998 — 31.12.2019), 11356 out of 53486 females with CD2_BENIGN_COLON died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_COLON	1.341 [1.22, 1.47]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 16065 out of 54524 males with CD2_BENIGN_COLON died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_COLON.

N-year risk	Females	Males
1	0.097%	0.274%
5	0.585%	1.585%
10	1.462%	3.781%
15	2.948%	7.304%
20	5.116%	12.564%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_COLON – Benign neoplasm: Colon

GWS hits: 39

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Colon

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints